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The complete sequencing of the human genome (2003), together with the ones of a 
number of microorganisms, has resulted in a large amount of new DNA sequences in 
the genetic databanks. However, the rapidly growing number of sequenced genes 
and genomes is outpacing by far the number of experimentally determined 
structures. One of the ultimate goals of genomic and proteomic projects is to 
determine the biological functions and cellular roles of all genes and proteins.  To 
determine the function, the knowledge of molecular structure of a protein becomes 
essential. Additionally, recent developments in proteomics technologies such as 
mass spectrometry, genome-scale yeast two-hybrid experiments and display cloning 
experiments are uncovering numerous novel protein-protein interactions. X-ray 
crystallography is rapidly evolving towards the determination of complex large 
macromolecular structures, nevertheless, limitations of resources and techniques 
have left many protein complex structures with key cellular role, yet unsolved. 
Computational techniques can help in filling, where possible, those gaps by 
predicting the tridimensional structure of newly sequenced proteins, and in predicting 
the structural arrangement of macromolecular complexes.The general purpose of this 
thesis was to master and apply methods for the optimization of enzyme design and 
for the characterization of protein-protein interactions. In particular, we focused on 
the application of these methods to molecular systems of biotechnological interest. 
The originality of the approach relies on the combination of computational biology 
tools with experimental procedures by correlating genotypic and phenotypic mutation 
data and by designing new experiments to enhance the functional properties of the 
studied molecules. The following systems of biotechnological interest have been 
analysed in this study: 1) Laccases from Pleurotus ostreatus.  To use laccases in 
new bio-based processes a deep understanding of the structure/function 
relationships of native enzymes is required with the aim to design molecules with 
improved performance, more suited for industrial applications. In this context the 
research has been aimed at characterizing molecular determinants of the activity of 
these enzymes, and at developing and characterizing new laccases obtained from 
rational design and direct evolution using P.ostreatus isoenzymes. 2): Interaction of 
Malaria Parasite-Inhibitory Antibodies with the Merozoite Surface Protein MSP119. 
More than 30 distinct antigens identified in various life cycle stages of the malaria 
parasite have been proposed as potential vaccine candidates, based on various 
observations such as the surface expression of the antigen on one or more life cycle 
stages. Several monoclonal antibodies (mAbs) directed against the C-terminus of 
MSP1 (MSP119) have been identified. Structural information on Plasmodium 
falciparum proteins is very scarce and therefore molecular modelling and molecular 
docking can be particularly useful in elucidating the details of protein-protein 
interactions in the parasite. The purpose of this part of the thesis was an investigation 
of the interaction between the protein MSP119 and two inhibitory antibodies Fab 12.8 
and Fab 12.10 by means of docking calculations. 3): Interactions of the human 
antiviral proteins APOBEC3F and APOBEC3G (A3F/G) with HIV-1 Vif. The human 
proteins APOBEC3F and APOBEC3G mediate this so-called innate immunity by 
selectively mutating and inhibiting the production of the viral DNA. Unfortunately, HIV 
has evolved a protein called the Virus Infectivity Factor (VIF), which binds to and 
subsequently destroys the APOBEC3F/G proteins. The purpose of this part of the 
study consisted in modelling the structures of APOBEC3F/G proteins and in using 
these models to rationalize mutation experiments targeted to key residues from each 
predicted dimer-interface. The native proteins and their mutants were evaluated by a 
subsequent assay of the antiviral and dimerization properties of such mutants. 
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L’enorme interesse verso discipline quali la genomica e la proteomica e’ strettamente 
correlato all’ambizioso scopo di determinare la funzione biologica e il ruolo cellulare 
di tutti i geni e delle proteine da essi espressi. 
Negli ultimi anni, in seguito al sequenziamento del genoma umano e di quello di 
innumerevoli microrganismi, il divario tra il numero di sequenze note e quelle di cui 
conosciamo la struttura e la funzione e’ aumentato notevolmente. In seguito a 
iniziative quali la genomica strutturale, il numero complessivo di strutture risolte 
mediante tecniche quali NMR e cristallografia ai raggi X ha subito un notevole 
incremento negli ultimi anni, tuttavia il divario tra la conoscenza della struttura 
primaria e quella terziaria è ancora enorme. 
Da un punto di vista evolutivo la funzione è più conservata della struttura e la 
struttura più conservata della sequenza; risulta chiaro, dunque, che la conoscenza 
della struttura tridimensionale di sitemi macromolecolari biologici rappresenta un 
passo fondamentale nella comprensione dell’informazione contenuta nel genoma. 
Nel caso in cui la struttura tridimensionale sia di difficile raggiungimento, la 
costruzione di modelli tridimensionali  può compensare in parte il divario esistente tra 
sequenze disponibili e strutture determinate sperimentalmente. La costruzione di 
modelli per omologia e la ricostruzione, tramite questi, di modelli macromolecolari 
complessi, associata all’analisi di mutanti opportunamente disegnati, permette 
l’ottenimento di una serie di informazioni utili circa la funzione della proteina, 
l’identificazione di importanti siti di legame, il disegno di nuovi farmaci. 
La funzione di una proteina e’ strettamente correlata al numero e al tipo di interazioni 
con altre proteine. Diventa sempre più importante, quindi, non solo conoscere la 
struttura tridimensionale della singola proteina, ma anche quella di complessi 
macromolecolari.  
Negli ultimi anni sono stati fatti notevoli progressi in questo campo e strutture 
complesse quali quella del Ribosoma e del Nucleosoma sono state determinate con 
un’elevata accuratezza. Tuttavia esistono ancora limitazioni tecniche che ostacolano 
la risoluzione strutturale su larga scala di complessi macromolecolari che abbiano un 
ruolo chiave nei processi cellulari. 
Il mio lavoro di tesi rappresenta un contributo in questa direzione: l’applicazione di 
metodi computazionali atti a caratterizzare interazioni tra proteine e tra proteine e 
ligandi  in sistemi molecolari di  interesse biotecnologico.  
L’originalità dell’approccio scelto sta nell’avere combinato metodi di biologia 
computazionale con procedure sperimentali, al fine di migliorare la conoscenza delle 
proprietà funzionali delle molecole in esame mediante la progettazione di mutanti 
sito-specifici e la loro successiva caratterizzazione. A tal fine, sono stati utilizzati 
programmi per la costruzione di modelli per omologia, programmi di Docking per la 
predizione di complessi enzima-substrato e anticorpo-antigene, e programmi per 
l’analisi delle superfici accessibili al solvente, capaci di determinare caratterizzare le 
relative superfici d’interazione.  
I sistemi oggetto di studio di questa tesi sono: 
 
Sistema 1: Laccasi da Pleurotus ostreatus 
 
Le laccasi sono enzimi appartenenti alla classe delle fenolo-ossidasi. Esse 
catalizzano l’ossidazione di fenoli, polifenoli e ammine aromatiche variamente 
sostituite con relativa riduzione di ossigeno molecolare ad acqua. Risulta dunque 
chiaro il loro impiego in campo biotecnologico. E’ infatti noto il loro utilizzo per i più 
 3 
 
disparati scopi: dalla demolizione della lignina alla bioremedation, che li impiega nel 
risanamento di siti inquinati da effluenti industriali. 
L’interesse nella realizzazione di enzimi che presentino una migliore o una nuova 
attività catalitica è un interessante aspetto che può essere utilizzato per ampliare le 
potenziali applicazioni biotecnologiche delle laccasi. 
Lo sviluppo di laccasi in nuovi bio-processi richiede una profonda conoscenza della 
relazione struttura/funzione degli enzimi nativi che porterebbe alla realizzazione di 
“nuovi” e migliori enzimi adatti per le applicazioni industriali. 
Differenti strategie possono essere applicate per modificare le proprietà enzimatiche: 
l’evoluzione guidata e la mutagenesi razionale. La prima richiede la conoscenza della 
sequenza del gene e ma non necessita della conoscenza della funzione e della 
struttura tridimensionale della proteina codificata; la seconda, invece, che prevede la 
pianificazione di esperimenti di mutazione sito-specifica, richiede la conoscenza della 
sequenza, della struttura tridimensionale, e ove possibile, anche del meccanismo 
d’azione enzimatica. 
Nel Laboratorio in cui si è svolto questo progetto sono state caratterizzate da un 
punto di vista termodinamico e catalitico tre laccasi, POXC, POXA1b e POXA3 dal 
fungo basidiomicete white-rot Pleurotus ostreatus, le cui strutture tridimensionali 
sono però ancora sconosciute.  
Il mio lavoro di tesi ha previsto la predizione dei modelli tridimensionali delle laccasi 
da P.ostreatus e la successiva caratterizzazione dei determinanti molecolari 
dell’attività catalitica. L’analisi e la comparazione delle sequenze primarie delle 
laccasi da P.ostreatus con le sequenze delle laccasi da basiodiomiceti a struttura 
nota, accoppiata con lo studio dei modelli 3D ottenuti, ha permesso di individuare 
delle singolari caratteristiche delle laccasi in esame. In particolare dall’allineamento è 
emerso che sia POXC che POXA1b presentano un prolungamento nella sequenza 
del C-terminale di sei e sedici amminoacidi rispettivamente. E’ stato dimostrato che 
la regione C-terminale influenza le proprietà delle laccasi, suggerendo un suo 
possibile ruolo funzionale nell’attività laccasica. I modelli tridimenionali ottenuti sono 
stati utilizzati per predire complessi enzima-substrato permettendo di individuare i 
residui in diretto contatto con il substrato (acido violurico), probabilmente responsabili 
dell’affinità dell’enzima per quest’ultimo. Date queste ulteriori analisi è stato 
identificato un residuo di arginina nel sito del legame al substrato in POXA3 al posto 
di un residuo di acido aspartico altamente conservato nella maggior parte delle 
laccasi da basidiomicete. Il residuo di acido aspartico nella zona del sito catalitico 
risulta probabilmente coinvolto nella stabilizzazione del catione ottenuto 
dall’ossidazione del substrato fenolico. Noi suggeriamo che la presenza di 
un’arginina porterebbe alla repulsione del radicale cationico e quindi ad una minore 
efficienza catalitica. 
Al fine di investigare il ruolo della regione C-terminale delle laccasi da P. ostreatus 
sono stati progettati e realizzati i mutanti tronchi POXA1b∆4, POXA1b∆16 e 
POXC∆6. Inoltre, allo scopo di caratterizzare i determinati molecolari coinvolti 
nell’interazione con il substrato, sono stati realizzati i mutanti POXA1b(D205R) e 
POXC(D210R). Successivamente tutti i mutanti sono stati espressi nel lievito S. 
cerevisiae. Per quanto riguarda POXC e i suoi mutanti, è stato possibile effettuare 
solo un’analisi qualitativa dalla quale è emerso che il mutante POXC∆6 risulta meno 
attivo dell’enzima POXC mentre il mutante POXC(D210R) sembrerebbe aver 
totalmente perso attività enzimatica. Per quanto riguarda POXA1b e i suoi tre mutanti 
(POXA1b∆16, POXA1∆4 and POXA1b(D205R)), è stato possibile purificare le tre 
proteine ed è stato possibile effettuare una caratterizzazione cinetica e catalitica 
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dalla quale è emerso che: la costante di Michaelis-Menten (KM) dei mutanti tronchi è 
paragonabile a quella dell’enzima wild-type rispetto a tutti i substrati saggiati, mentre 
il valore di KM di POXA1b(D205R) è circa il doppio rispetto a quella della proteina 
ricombinante POXA1b. Questi dati evidenziano l’importanza del residuo Asp 
nell’interazione con il substrato, essendo questa l’unica differenza nelle relative 
sequenze. Inoltre, dall’analisi della stabilità a differenti pH è risultato che i mutanti 
tronchi sono più stabili del wild-type a pH acidi, mentre tutti i mutanti in esame 
perdono drasticamente la peculiare stabilità a pH alcalini di POXA1b. Inoltre, la 
termoresistenza effettuata a 60°C ha mostrato che P OXA1b∆16 e POXA1b(D205R) 
sono sensibilmente meno resistenti di POXA1b. 
Dai dati ottenuti si può dedurre che il residuo di acido aspartico presente nel sito 
attivo è direttamente coinvolto nell’interazione con il substrato e che la sostituzione 
con un residuo di arginina potrebbe generare un riarrangiamento della struttura che 
avrebbe ripercussioni sulla stabilità della proteina. Inoltre l’estremità C-terminale 
sembrerebbe essenziale nello stabilizzare la proteina in condizioni estreme di 
temperatura e di pH. Un’analisi puramente computazionale è stata invece effettuata 
su alcuni mutanti generati dalla Dott. G. Festa mediante la tecnica dell’evoluzione 
guidata (Tesi di dottorato  2006, Università di Napoli “Federico II”).  
Simulazioni di dinamica molecolare in soluzione sul modello 3D di POXA1b e sui 
mutanti che presentavano le migliori performaces catalitiche hanno permesso di 
integrare i risultati sperimentali ottenuti e di razionalizzare a livello molecolare la 
diversa stabilità e la diversa attività.  
 
Sistema 2: Interazionie di anticorpi monoclonali antimalarici con la proteina di 
superficie MSP119 da Plasmodium falciparum 
 
P. falciparum, uno dei quattro potozooi responsabili della malaria, rappresenta la 
specie non solo più diffusa, ma anche la più virulenta. La resistenza sempre 
crescente di questo ceppo ai farmaci più diffusi e a basso costo, ha creato 
un’urgente bisogno di sviluppare nuove strategie per debellare la malattia. Dato l’alto 
costo dei trattamenti fin’ora adoperati è chiaro che l’interesse per lo sviluppo di un 
vaccino che possa abbattere non solo la mortalità causata dalla malattia ma anche il 
suo costo sta crescendo notevolmente.  
Il parassita responsabile della malaria presenta svariati antigeni, riconosciuti dal 
sistema immunitario, che variano a seconda del momento del ciclo di vita del 
parassita stesso. L’identificazione di questi è fondamentale per lo sviluppo di un 
vaccino multifasico che potrebbe offrire una completa protezione. Le proteine sulla 
superficie del merozoite sono dei targets eccellenti, in quanto possono essere 
facilmente riconosciuti dagli anticorpi. Una delle proteine di superficie più studiata è 
MSP1 (Merozoite Surface Protein 1) da P. falciparum. MSP1 è inizialmente 
sintetizzata come una preproproteina di circa 200 kDa. Essa subisce due processi di 
maturazione proteolitica che rilasciano sulla superficie del merozoite un frammento di 
19 kDa denominato MSP-119. La struttura cristallografica della proteina MSP-119 è 
stata recentemente risolta mediante NMR e, inoltre, esperimenti di cross-saturation 
effettuati su complessi proteina-anticorpo hanno permesso di individuare il residui 
dell’antigene in diretto contatto con gli anticorpi monoclonali inibitori Fab12.8 e 
Fab12.10. In particolare è risultato che l’antigene interagisce con entrambi gli 
anticorpi utilizzando la stessa faccia. 
Lo scopo di tale sessione è stato quello di predire l’interazione antigene-anticopo e di 
caratterizzare i residui degli anticorpi coinvolti nell’interazione.  
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Le strutture dei due anticorpi non sono state ancora risolte, ed è stato quindi 
necessario prima di tutto costruire i modelli tridimensionali di entrambi gli anticorpi 
Fab12.8 e Fab12.10. Successivamente per la predizione dei complessi anticorpo-
antigene è stato utilizzato un programma di docking rigido, ZDOCK, che è risultato il 
migliore per lo studio di questo tipo di interazioni. Per ogni complesso sono state 
predetti 2000 complessi che sono poi stati selezionati in base ai dati sperimentali 
NMR a nostra disposizione. La strategia utilizzata è stata verificata utilizzando la 
struttura cristallografica del complesso MSP119-FabG12.17 per appurare che tale 
metodo fosse valido. La struttura cristallografica MSP119-FabG12.17 e i complessi 
selezionati sono stati successivamente sottoposti a simulazioni di dinamica 
molecolare al fine di migliorare le iterazioni antigene-anticorpo. Dalle analisi 
effettuate abbiamo dedotto che l’antigene si posiziona in maniera differente rispetto 
gli anticorpi e sembrerebbe che tale posizione è influenzata dalla presenza di residui 
positivi sulla superficie degli anticorpi. L’identificazione dei residui responsabili del 
legame sarà utilizzata per la progettazione di nuovi esperimenti che permetteranno di 
migliorare l’affinità  dei complessi antigene-anticorpo. 
 
Sistema 3: Interazioni di protein uname antivirali  APOBEC3F e APOBEC3G 
(A3F/G) con HIV-1 Vif. 
 
Negli ultimi anni è emerso che le cellule umane presentano una difesa immunitaria 
contro le infezioni di lentivirus ed in particolare contro il noto virus dell’HIV. Tale 
difesa immunitaria è ad opera di due proteine omodimeriche, APOBEC3F e 
APOBEC3G, appartenenti alla famiglia delle citosina-deamminasi (CDA). Questa 
superfamiglia è largamente distribuita ed ha un ruolo fondamentale in diversi 
meccanismi enzimatici. Questa classe di enzimi converte la citosina a uracile 
producendo quindi un effetto sulle funzioni fisiologiche della cellula. In particolare le 
proteine APOBEC presentano uno o più domini che legano lo zinco mediante  una 
sequenza specifica H-X-E-X23-28-P-C-X2-4-C (dove X sta per ogni amminoacido), 
denominati CDA. Sfortunatamente, il virus dell'AIDS ha sviluppato una contro difesa: 
produce infatti una proteina chiamata VIF (Fattore Virale Infettivo) la quale innesca la 
distruzione dei limitatori retrovirali, impedendo così le mutazioni del suo DNA. 
Individuare i determinanti molecolari responsabili di tale interazione potrebbe 
condurre al disegno di nuove proteine A3G/F che presentino una minore affinità 
verso la proteina VIF. 
Solo di recente è stata risolta la struttura cristallografica di un membro della famiglia 
delle APOBEC, la proteina APOBEC2 (A2). A2 è una proteina tetramerica che 
presenta 4 domini CDA. I quattro monomeri interagiscono tra di loro formando una 
struttura allungata e piatta. Tale struttura è certamente atipica paragonata con le 
altre strutture risolte  che presentano un folding globulare. 
La struttura di A2 è stata quindi utilizzata per predire le strutture tridimensionali dei 
monomeri e successivamente dei dimeri formati da A3G/F. Ancora non è noto come i 
monomeri di A3G/F interagiscano per formare il dimero, ma il tipo di dimerizzazione 
sembra limitato alle possibili interazioni testa-testa o coda-coda dei monomeri. I 
possibili dimeri molecolari sono stati predetti per entrambi i sistemi utilizzando il 
programma MODELLER che permette di predire e calcolare l’energia di centinaia di 
modelli generati. I modelli che presentavano minore energia sono stati selezionati, in 
particolare due famiglie di modelli sono state generate: una estesa ed allungata (che 
presenta un folding analogo a quello della proteina stampo) e  quella piegata che 
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presenta un folding leggermente diverso, con la superficie di contatto tra i due 
monomeri piu’ estesa, formando una struttura a piegata a V inversa.  
Le interfacce tra i monomeri sono state analizzate valutando non solo i residui in 
contatto tra i monomeri ma anche la natura elettrostatica dell’interazione. I dati 
ottenuti per la dimerizzazione testa-testa sono in accordo con i dati sperimentali 
presenti in letteratura, in particolare all’interfaccia è stata riscontrata la presenza di 
residui responsabili dell’interazione con VIF. I dati ottenuti mediante l’analisi 
computazionale sono in accordo con recenti risultati sperimentali di mutagenesi sito-
specifica effettuati dal gruppo del Prof. Malin del King’s College di Londra ed hanno 
permesso di individuare i residui che influenzano la dimerizzazione; in particolare, tali 
analisi hanno evidenziato che i monomeri interagiscono mediante i domini N-
terminale. Infatti, l’analisi approfondita sui modelli ha messo in evidenza che non solo 
nella dimerizzazione testa-testa sono coinvolti i residui responsabili dell’interazione 
con VIF, ma anche che questo tipo di interazione produce all’interfaccia del dimero 
una regione carica positivamente, particolarmente adatta ad alloggiare il 
ssDNA/RNA, molecola ben nota per la sua natura acida. 
Simulazioni di dinamica molecolare sono state effettuate sui dimeri testa-testa come 
pure sulla struttura cristallografica di A2 al fine di approfondire la caratterizzazione 
della natura dell’interazione di tali proteine. Dalle analisi effettuate sulle dinamiche si 
evince che durante la simulazione i monomeri si avvicinano per ottimizzare 
l’interazione e che questo parziale movimento, seppur lieve, origina un 
riarrangiamento delle interfacce. L’analisi dei residui in contatto prima e dopo le 
simulazioni hanno evidenziato che due nuove regioni dei monomeri sono in contatto 
e sono stati individuati nuovi residui che stabilizzano l’interazione tra i monomeri. I 
dati forniti dall’analisi computazionale potranno essere utilizzati per progettare nuovi 
esperimenti di mutagenesi per validare i dati ottenuti e per caratterizzare 
ulteriormente i residui responsabili della dimerizzazione. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 1 
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Purpose of the thesis 
The general purpose of this thesis was to master and apply methods for the 
optimization of enzyme design and for the characterization of protein-protein 
interactions. In particular, we focused on the application of these methods to 
molecular systems of biotechnological interest. 
The originality of the approach relies on the combination of computational biology 
tools with experimental procedures by correlating genotypic and phenotypic mutation 
data and by designing new experiments to enhance the functional properties of the 
studied molecules. 
 
The following systems of biotechnological interest have been analysed in this study:  
 
• System 1: Laccases from Pleurotus ostreatus.  
Laccases belong to the multicopper enzyme family and are phenol-oxidases that 
catalyze the oxidation of a wide variety of substrates and they have been used in a 
number of biotechnological applications [1]. 
The development of new bio-based processes using laccases requires a deep 
understanding of the structure/function relationships of native enzymes and the 
design of molecules with improved performance that are more suited for industrial 
applications. In this context the research has been aimed at characterizing molecular 
determinants of the activity of these enzymes, and at developing and characterising 
new laccases using P.ostreatus isoenzymes. 
 
• System 2: Interaction of Malaria Parasite-Inhibitory Antibodies with the 
Merozoite Surface Protein MSP119. 
The development of vaccine candidates for the malaria parasite would provide a way 
of alleviating the devastating effects of this disease in the world. No effective vaccine 
has been developed yet, mainly because there is no scientific consensus on the best 
approach to the problem. So far, an enormous amount of resources has been wasted 
on trials of ineffective vaccines, while one should focus on generating better 
candidates. This is the outcome of a report released on the 17th September 2007 by 
the George Institute for International Health in Sydney, Australia. The report 
documents the status and future prospects of 47 vaccines and 21 drugs in various 
stages of development. The vaccine being in a more advanced stage has been 
developed by GlaxoSmithKline (GSK). It should enter phase III trials in 2008 and 
potentially licensed in 2012. That vaccine nearly halved severe malaria in a 2005 trial 
on 2,000 children younger than 5 years in Mozambique [2]. Nevertheless the report 
claimed a need of more basic research on malaria. 
More than 30 distinct antigens identified in various life cycle stages of the malaria 
parasite have been proposed as potential vaccine candidates, based on various 
observations, such as the surface expression of the antigen on one or more life cycle 
stages. Recent protection studies in the monkey model system have shown 
promising results with a 42 kDa MSP1 protein produced in baculovirus [3]. Several 
monoclonal antibodies (mAbs) directed against the C-terminus of  MSP1 (MSP119) 
have been identified; some inhibit invasion of erythrocytes in vitro [4], while some 
inhibit both, secondary processing of MSP1 and erythrocyte invasion [5].  
Structural information of Plasmodium falciparum proteins is very scarce and therefore 
molecular modelling and molecular docking can be particularly useful in elucidating 
the details of protein-protein interactions in the parasite. 
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The purpose of this part of the thesis was an investigation of the interaction between 
the protein MSP119 and two inhibitory antibodies by means of docking calculations. 
 
• System 3: Interactions of the human antiviral proteins APOBEC3F and 
APOBEC3G (A3F/G) with HIV-1 Vif. 
In recent years it has emerged that the cells of the immune system themselves 
harbour an ancient defense mechanism against infection by viruses that takes place 
in the interior of the cell. The human proteins APOBEC3F and APOBEC3G mediate 
this so-called innate immunity by selectively mutating and inhibiting the production of 
the viral DNA. Unfortunately, HIV has evolved a protein called the Virus Infectivity 
Factor (VIF), which binds to and subsequently destroys the APOBEC3F/G proteins. 
Very recently, the crystal structure of the APOBEC2 (A2) family member has been 
solved[6]. Although A2 has no known function and certainly does not inhibit HIV, its 
reported structure provides an ideal template for structural modelling of the A3F/G 
proteins. 
The purpose of this part of the study consisted in modelling the structures of 
APOBEC3F/G proteins and in using these models to rationalize mutation 
experiments targeted to key residues from each predicted dimer-interface. The native 
proteins and their mutants were evaluated by a subsequent assay of the antiviral and 
dimerization properties of such mutants [7]. 
 
Why computational methods? 
Whole genome sequencing of a number of organisms, including the complete human 
genome (2003), have produced a large amount of genomic DNA sequences in the 
genetic databanks. This enormous amount of data would contribute to a complete 
picture of biological information only if all the links between genome sequence and 
protein structure and function were established. However, the rapidly growing 
number of sequenced genes and genomes is heavily outpacing the number of 
experimentally determined structures. Genome annotation has produced a larger gap 
between the number of known protein sequences and the number of solved three-
dimensional structures. The latest data from SWISS-PROT-TrEMBL (non-redundant 
database) contains over 45.000 protein sequences. 
Although there is a considerable gap between the number of known sequences and 
the number of available 3D structures, the knowledge of three-dimensional protein 
structures is crucial for answering many biological questions. Firstly, structure is more 
conserved than sequence during the course of evolution [8]. Secondly, function is 
more conserved than structure, but function is often attributed to a few spatially 
proximate atoms; therefore, the knowledge of the 3D structure is a fundamental step 
in the assessment of the function of a new protein.  
The quest for more structural knowledge has inspired the formation of a structural 
genomics consortium that is dedicated to the production of representative 
experimental structures for all classes of protein folds [9]. Because it is difficult, 
expensive and time-consuming to obtain experimental structures from methods such 
as X-ray crystallography and protein NMR for every protein of interest, protein 
structure prediction methods can provide useful structural models for generating 
hypotheses about protein function and for directing further experimental work. 
Therefore, this scenario represents a unique opportunity for theoretical methods to 
help in filling the sequence/structure gap. The development of efficient structure 
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prediction methods can contribute to the determination of structures of proteins with 
high sequence identity (>30%) with other proteins of known 3D-structure. 
 
 Comparative homology modeling 
Protein structure predictions can be used to obtain accurate protein structure models 
for evolutionarily related sequences that share similar structures [8, 10]. This 
technique is called “homology modeling” or “comparative modeling”. It is a 
computational tool to construct an atomistic model of a protein from its amino acid 
sequence (the "query sequence" or "target"). Almost all homology modelling 
techniques use one or more known protein structures (known as "templates" or 
"parent structures") that are likely to resemble the structure of the query sequence.  
From the sequences of query and templates a sequence alignment is created that 
maps residues in the query sequence to the residues in the template sequence. The 
sequence alignment and the template structure are then used to generate a 
structural model of the target. As a consequence, a three-dimensional model of a 
protein can be built from a related protein or proteins of known structure that shows a  
sequence identity above a certain threshold (around 30%).  
Two important factors influence the ability to predict accurate models: the 
correctness of the alignment and the role of structural conservation between the  
protein of interest (target) and the template [10, 11]. On the other hand, sequence 
identity between target and template is not the only important parameter to calculate 
approximately the quality of a comparative model [11, 12]. A good evaluation of the 
model quality is the distribution of sequence identity in a multiple sequence alignment  
comprising the target, template and intermediate homologous sequences [13]. 
Generally, models based on 30% sequence identity seem to be sufficiently accurate 
for molecular replacement techniques used in X-ray crystallography [14]. The quality 
of comparative models tends to decrease  with increasing evolutionary distance 
between target and template [10-12]. However, when template and target share the 
same function and specificity, usually functional regions are structurally better 
conserved than other regions [12]. When their function or specificity differs, larger 
structural changes are expected in functional regions [15]. 
Accurate modeling of the differences between similar structures (insertions and 
deletions) is one of the most biologically relevant applications of comparative 
modelling, because these structural changes usually modify functions and/or 
specificities.  
Very recently [16] protein structure prediction methods have been shown to be 
helpful in predicting the crystallographic phase with surprising accuracy. These 
results suggest that the combination of high-resolution structure prediction with state-
of-the-art phasing tools could become an integral part of the process of X-ray 
structure resolution in the future. 
The insights gained from comparative models may be used to identify critical 
residues that are involved in catalysis, binding or structural stability. The 3D model 
can be a departure point to examine protein–protein interactions, to design new 
drugs and to devise future experiments. 
Used in conjunction with molecular dynamics simulations, homology models can help 
in generating hypotheses about the kinetics and dynamics of protein interactions, as 
demonstrated by excellent studies on the ion selectivity of a potassium channel [17]. 
Large-scale automated modelling of all identified protein-coding regions in a genome 
has been performed for the yeast Saccharomyces cerevisiae, resulting in nearly 
1000 quality models for proteins whose structures had not yet been determined at 
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the time of the study, and identifying novel relationships between 236 yeast proteins 
and other previously solved structures [18]. 
  
Structure Prediction of Protein Complexes 
One of the ultimate goals of genomic and proteomic projects is to determine the 
biological functions and cellular roles of all genes and proteins. Additionally, recent 
developments in proteomics technology such as mass spectrometry, genome-scale 
yeast 2-hybrid experiments and display cloning experiments are uncovering 
numerous novel protein-protein interactions. These interactions influence directly and 
indirectly the biological networks of which they are a part. X-ray crystallography has 
provided us with many structures of protein–protein complexes, but limitations of 
resources and experimental design have left many protein complex structures yet 
unsolved. 
While techniques such as homology modeling and mutational analysis yield some 
information about binding sites, more information is needed to understand the nature 
of protein–protein interactions. Thus, it is useful to employ protein docking to predict 
complex structure. By means of docking it is possible to identify the residues that are 
directly involved in binding and to reveal the nature of the interface itself.  
Protein–protein docking can be defined as the computational determination of the 
complex structure between two proteins, given the coordinates of the individual 
proteins. This methodology is often used to predict protein-DNA, protein-RNA and 
protein-small molecule interactions.  
Predictive docking procedures start from the individually determined (unbound) 
structures of two proteins and they aim at predicting the complex structure. Binding 
site information rarely accompanies novel protein-protein interactions uncovered by 
proteomics analyses. All docking programs contain 1. a scoring function to 
discriminate between near-native docked orientations and incorrect orientations, and 
2. a search algorithm that is designed to sample rapidly all possible docking 
orientations. Proteins undergo conformational changes upon complex formation to 
varying extent. Even though structural flexibility is mostly restricted to surface side 
chains [19], the innate flexibility renders protein docking extremely difficult. The 
algorithm by Abagyan and colleagues [20, 21] allows for surface side chain flexibility; 
however, such algorithms typically require hundreds of hours of computation for each 
complex [20], which is not feasible for genome-scale applications. The alternative is 
to adopt the rigid-body approach, which samples only the six rotational/translational 
degrees of freedom, but uses target functions that are tolerant to some overlap of the 
two proteins being matched. ZDOCK (rigid-body docking) [22] is an accurate 
accurate program with a simple target function. In particular, it is essential to have 
some correct predictions among the complexes that are produced. The terms 
employed during initial stage docking are shape complementarity, desolvation free 
energy and electrostatic energy [23]. The ZDOCK program uses two PDB files as 
input (the two molecules to dock) and creates a list of top-scoring ligand orientations 
as output. For every rotational orientation, ZDOCK keeps the 10 best translational 
orientations. The basic search algorithm samples exhaustively the entire rotational 
and translational space of the ligand with respect to the receptor, which remains fixed 
at the origin. For every rotation, the algorithm rapidly scans the translational space 
using fast Fourier transformation (FFT). 
Three lists are kept at all times, each containing ligand orientations: the first list with 
the best shape complementarity score SSC, the second list with the best shape 
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complementarity and desolvation score αSSC + SDS and a third list with the best 
shape complementarity, desolvation and electrostatics score αSSC + SDS + βSELEC.  
Shape complementarity (SC) is the most basic ingredient of all scoring functions for 
docking. As the name implies, it is a geometric descriptor, stemming from the 
practical observation that protein surfaces are complementary to each other at the 
binding interface.  
The total Desolvation Free Energy (DS) of complex formation (SDS; DS stands for 
desolvation) is calculated by summing over the Atomic Contact Energy (ACE) scores 
of all atom pairs between the receptor and the ligand that are within 6 Å distance 
[23]. ACE is a desolvation free energy measure, defined as the free energy of 
replacing a protein-atom/water contact with a protein-atom/protein-atom contact. 
Combined with an electrostatics term, ACE has been shown to accurately predict the 
free energy changes associated with transferring amino acids from the protein 
interior to water, to predict site-specific mutations of hydrophobic amino acids and  to 
assess protease-inhibitor binding [24-27]. 
The electrostatics energy (ELEC) can be expressed as a correlation between the 
electric potential generated by the receptor and the charges of the ligand atoms, as 
described by the Coulomb formula [28]. Additionally, grid points in the core of the 
receptor are assigned a value of 0 for the electric potential to eliminate contributions 
from non-physical receptor-core/ligand contacts. 
However, in an unbound docking study, surface side chains tend to be at non-optimal 
positions and therefore the resulting electrostatic energy can be inaccurate and even 
unrealistic. Artifacts can also be introduced by the grid representation.    Therefore 
the electrostatics energy SELEC is scaled by a factor β. Also the shape 
complementarity score has been weighted by a scaling factor α. The final target 
function is:  
 
S=αSSC + SDS  + βSELEC                                                          (1.1) 
 
The default values for scaling factors are α= 0.01 and β= 0.06. 
One useful feature of ZDOCK is that it allows the user to “block” residues, making it 
unfavorable for selected residues to be in the interface. This can be used, for 
example, to constrain the antigen of an antibody–antigen complex to be bound to the 
CDR loops of the antibody. It is also useful when experimental and/or biological 
information is known regarding the location of the binding site. Blocking is 
accomplished by assigning a special atom type to all atoms of the residues to be 
prohibited from the putative binding site.  
Protein docking methods have improved substantially over the past few years. This 
can be seen from results of the Critical Assessment of Predicted Interactions 
(CAPRI) – the first community-wide experiment devoted to protein docking [29].  
 
Molecular Dynamics Methods 
Molecular Dynamics (MD) is a computer simulation technique in which the time 
evolution of a set of interacting atoms is computed by integrating their equations of 
motion. Therefore, MD allows us to view how a molecular system evolves through 
time and to derive average properties of the system, given a  simulation of sufficient 
length. MD is particularly useful when the system cannot be studied by experimental 
methods. 
The equations of motion can only be solved numerically for a multi-body problem. To 
calculate the dynamics of the system (i.e. the position of each atom as a function of 
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time), Newton's classical equations of motion are solved for each atom given an 
empirical force field: 
 
                                                  (1.2) 
 
The force on each atom is the negative of the derivative of the potential energy with 
respect to the position of the atom: 
 
                                                                (1.3) 
 
Once the coordinates of the atoms of a starting structure and their velocities are 
defined, the force acting on each atom can be calculated for each point in time t + dt 
and a new set of coordinates can be generated. The repetition of this procedure 
generates a molecular trajectory corresponding to the time-dependent fluctuations of 
the atomic positions. The accuracy of the simulations is directly related to the 
potential energy function that is used to describe the interactions between particles. 
In MD a classical potential energy function is used that is defined as a function of the 
coordinates of each of the atoms. 
The potential energy function is separated into terms representing covalent 
interactions and non covalent interactions.  
The covalent interactions may be described by the following terms: 
 
                                                  (1.4) 
 
                                                (1.5) 
 
                                (1.6) 
 
                                              (1.7) 
 
 
The equations correspond to two, three, four and four body interactions, respectively. 
These interactions are represented by harmonic potentials for the bond lengths ri,, for 
the bond angles θi, for the improper dihedral (out of the plane) angle ξi and by a more 
complex potential for the dihedral angles Фi. The non-covalent  (non-bonded) 
interactions, which correspond to interactions between particles separated by more 
than three covalent bonds, are usually described by Coulomb's law 
 
                                                    (1.8) 
 
for the electrostatic interactions and by a Lennard-Jones potential: 
 
                                                                  (1.9) 
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for the van der Waals (vdW) interactions, where rij is the atomic distance between 
particles i and j. The force field parameters describe the strength of the interactions. 
For bonded interactions parameters are defined for bond stretching, bond bending 
and torsional rotation. Another set of parameters determines the strength of non-
bonded electrostatic and van der Waals interactions.  
Electrostatic interactions are generally represented by point charges located at the 
center of the atom.  
It should be kept in mind, however, that MD is affected by several limitations. Firstly, 
MD is computationally very demanding and the computational load scales with  the 
square of the system size. Simulation times are currently limited to hundreds of 
nanoseconds or a few microseconds at most. The phenomena that can be explored 
must occur with sufficient statistical significance within time scales that are 
encompassed by the computation. 
How the system evolves through time is specified by the force field and by an 
integration time step that determines where the atoms will be positioned at time t + 
dt. MD requires the use of a very small time-step (1-2 fs) to achieve accurate results, 
because small time-steps limit the approximations that are introduced by the 
numerical integrator. This limits the overall scope of the simulated time and the 
computable properties.  
According to statistical thermodynamics, physical quantities are represented by 
averages over configurations belonging to a certain statistical ensemble. A trajectory 
obtained by molecular dynamics provides such an ensemble. Therefore, a 
measurement of a physical quantity by simulation is simply obtained as an arithmetic 
average of the various instantaneous values adopted by that quantity during the MD 
run. Statistical thermodynamics is the link between the microscopic ensembles and 
and the macroscopic properties. In the limit of an exact force field and very long 
simulation times, one could expect the phase space to be fully sampled and in that 
limit the averaging process would yield exact thermodynamic properties. In practice, 
MD runs are always of finite length and one should exert caution when judging the 
sampling quality. An important constraint in deriving average properties is to extract 
configurations only from an ensemble at thermal equilibrium. Therefore, MD 
simulations start generally with an equilibration phase. Once equilibrium is reached, 
the simulation enters the production phase. The production run should be long 
enough to sample the property of interest with sufficient statistical significance.  
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Introduction: Industrial use of enzymes 
The systematic and indiscriminate exploitation of the resources of our planet has 
caused growing problems for the environment; for this reason the development of 
environmentally friendly and, at the same time, economically sustainable 
technologies has acquired increasing interest during the last few years. 
Industrial biotechnology, also known as white or environmental biotechnology, is the 
application of nature’s toolset for the sustainable production of biochemicals, 
biomaterials and biofuels from renewable resources, using living cells and/or their 
enzymes. This results generally in cleaner processes with minimum waste generation 
and energy use. Current practice in industrial biotechnology demonstrates that the 
social, environmental and economic benefits of bio-based processes go hand in 
hand. The potential economic value of industrial biotechnology for the chemical 
industry alone is estimated to be € 11-22 billion per annum by 2010. McKinsey & 
Company estimate that biotechnology could be applied in the production of 10 to 
20% of all chemicals sold by 2010, starting from the current level of about 5%. 
Industrial biotechnological strategies based on biocatalytic processes represent an 
area of great interest. The recent sequencing of the human genome and the 
associated sequencing of bacterial and yeast genomes have also played their part in 
this area. In addition, the fields of metabolic engineering, bioinformatics and 
computer-based modelling as well as process optimization are opening up 
opportunities for new products and cost reductions.  
The enzyme industry already from the eighties started to exploit the developments 
taking place in the fields of biotechnology and genetic engineering. The advantages 
offered by enzymes compared to conventional chemical catalysts rely on their 
biodegradability and their extreme selectivity. It is well known that natural enzymes 
are capable of catalysing reactions with up to 1017-fold rate accelerations [1], and 
with exquisite control of regio- and stereochemistry. Such control makes the use of 
enzymes very attractive as an alternative to traditional catalysts in the synthesis of 
complex molecules, especially when chemical routes are difficult to implement [2, 3]. 
This meant a rapid and radical development in enzyme production technologies to 
improve the production efficiency and the product quality of enzymes through 
genetically modified organisms.  
Enzymes  have replaced classical reagents in numerous applications, e.g. proteases 
[4] and cellulases [5] in place of phosphates in the detergent sector, and amylases [6] 
and pectinases [7] instead of sodium hydroxide in the textile industry. The list of 
enzyme applications grows day by day, bringing with it a list of significant social and 
environmental benefits: enzymes, in fact, are biodegradable and come from 
renewable energy sources, they work under relatively mild conditions of pH and 
temperature and tend to offer selectivity in both reactant and product stereochemistry 
[8].The research of new, efficient and environmentally benign processes for several 
industrial purposes has increased interest in the ‘green’ catalysts.  
Laccases represent one of these ‘ecofriendly’ enzymes. Their uses span from the 
textile to the pulp and paper industries, from food applications to bioremediation 
processes; therefore, laccases have received much attention in recent years. 
 
Biotechnological applications of laccases  
Laccases (EC 1.10.3.2, p-diphenol: dioxygen oxidoreductase) are part of a larger 
group of enzymes named multicopper oxidases, which includes among others 
ascorbic acid oxidase and ceruloplasmin. 
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Laccase is one of the very few enzymes that have been studied since the end of 19th 
century. In the 1883 Yoshida was the first to describe a laccase as a component of 
the Resin ducts of the lacquer tree Rhus vernicifera and in 1985 Bertrand 
characterised a laccase as a metal containing oxidase [9]. This makes laccase one of 
the earliest enzymes ever described. Although known for a long time, laccases 
attracted considerable attention only after the beginning of studies of enzymatic 
degradation of wood by white-rot  fungi. 
Laccases are commonly found in plants, where they participate in the radical-based 
mechanisms of lignin polymer formation [10] and in fungi, where laccases probably 
play several roles including morphogenesis, fungal plant-pathogen/host interaction, 
stress defense and lignin degradation [11].  
Laccases are phenol-oxidases that catalyze the oxidation of a wide variety of 
substrates, comprising substituted phenols, polyamines and aryl diamines. The one-
electron oxidation of the reducing substrate occurs concomitantly with the four-
electron reduction of molecular oxygen to water. As these enzymes have low 
substrate specificity, they can oxidize a variety of substrates, either of natural or 
synthetic origin. In the presence of small molecules, capable to act as electron 
transfer mediators, laccases are also able to oxidise non-phenolic structures with 
redox potentials higher than their own [12]. 
It is well known that laccases have been applied to numerous processes such as: i) 
pulp delignification, where laccases can be used in the enzymatic adhesion of fibres 
in the manufacturing of lignocellulose-based composite materials such as 
fibreboards. Laccases have been proposed to activate the fibrebound lignin during 
manufacturing of the composites, thus, resulting in boards with good mechanical 
properties without toxic synthetic adhesives [13]; ii) textile industry, where the use of 
laccases is growing very fast, since besides to decolourise textile effluents as 
commented above, laccases are being used to bleach textiles and even to 
synthesise dyes [14]. Related to textile bleaching, in 1996 Novozyme (Novo Nordisk, 
Denmark) launched a new industrial application of laccase enzyme in denim 
finishing: DeniLite®, the first industrial laccase and the first bleaching enzyme acting 
with the help of a mediator molecule; iii) food industry, in which the potential 
applications of laccase [15] have been described recently in relation to 
bioremediation, beverage processing, ascorbic acid determination, sugar beet pectin 
gelation, baking and as a biosensor [16]. 
The white-rot fungus (WRF) P. ostreatus produces at least eight different laccase 
isoenzymes, five of which have been isolated and characterized [17-21]. Although 
the POXC protein (59-kDa with pI 2.7) is the most abundant in cultures, both, extra- 
and intracellular, the highest mRNA production was detected in POXA1b, which is 
probably mainly intracellular or cell wall-associated as it is cleaved by an extracellular 
protease [19, 21]. POXA1b and POXA1w isoenzymes exhibit a similar molecular 
weight around 61 kDa. Moreover, P. ostreatus produces two heterodimeric enzymes 
POXA3a and POXA3b consisting of large (61-kDa) and small (16- or 18-kDa) 
subunits. The production of laccase isoenzymes in P. ostreatus is regulated by the 
presence of copper and the two dimeric isoenzymes have only been detected in the 
presence of Cu ions [18, 22]. It should be noted that POXA1b exhibits atypical 
stability at alkaline pH. This is of interest for its use in the elimination of industrial 
effluents, often characterized by strongly alkaline pH values besides high 
concentrations of phenols. The oxidative enzymatic system of white-rot fungi is also 
capable of catalysing the degradation of various xenobiotic substances and dyes 
[23]. Generally, these xenobiotic compounds are removed slowly and tend to  
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accumulate in the environment. Due to the high degree of toxicity, their accumulation 
can cause severe environmental problems. A large number of these molecules, e.g. 
those structurally related to natural laccase substrates, are readily degraded or 
removed by microorganisms found in soil and water. The detoxification potential of 
white-rot fungi can be harnessed thanks to emerging knowledge of the physiology of 
these organisms as well as of the catalytic and stability characteristics of their 
enzymes.  
 
Structural properties of laccases 
Numerous laccase isoenzymes have been identified in many fungal species. 
Generally, more than one isoenzyme is produced in white-rot fungi.  Until now, more 
than hundred laccases have been purified and characterised from fungi. It is possible  
to draw some general conclusions about laccases.  
Typical fungal laccase is a monomeric protein of approximately 60–70 kDa with an 
acidic isoelectric point around pH 4.0 (Table I). It seems that there is considerable 
heterogeneity in the properties of laccases isolated from ascomycetes, especially 
with respect to molecular weight.  
Laccases are glycoproteins like many fungal extracellular enzymes; the extent of 
glycosylation usually ranges between 10% and 25%. Glycosylation of fungal 
laccases is one of the main problems for their heterologous production. It was 
proposed that in addition to the structural role, glycosylation can also participate in 
the protection of laccase from proteolytic degradation [24].  
Laccases contain four copper ions distributed into three sites, defined according to 
their spectroscopic properties. The catalytic ability of this enzyme family is 
guaranteed by the presence of these different copper centres in the enzyme 
molecule; based on spectroscopic analysis, which reflects geometric and electronic 
features, copper centres are differentiated as Type 1 Cu (T1), or blue copper centres, 
Type 2 (T2) or normal copper centres, and Type 3 (T3) or coupled binuclear copper 
centres [25-27] (Fig. 2.1(a)-(b)). 
The T1 copper, which is the primary oxidation site, is characterized by a strong 
absorption around 600 nm, which gives rise to the typical blue colour of the copper 
oxidase. The T2 copper exhibits only weak absorption in the visible region and is 
electron paramagnetic resonance (EPR)-active, whereas the two copper ions of the 
T3 site are EPR-silent due to an  antiferromagnetic coupling mediated by a bridging 
hydroxyl ligand (see Fig.2.1). 
Figure 2.1: Laccase copper sites and 
their environment. (a) The trinuclear 
T2/T3 site. Copper coordinations are 
indicated with dark lines. (b) The T1 site 
and the neighbouring 2,5-xylidine ligand 
(green model). Image taken from 
reference [28]. 
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Table I. Properties of fungal laccases [9]. 
Property n Median Q25 Q75 Min Max 
Molecular weight (Da) 103 66 000 61 000 71 000 43 000 383 000 
pI 67 3.9 3.5 4.2 2.6 6.9 
Temperature optimum (°C) 39 55 50 70 25 80 
pH optimum 
ABTS 49 3.0 2.5 4.0 2.0 5.0 
2,6-Dimethoxyphenol 36 4.0 3.0 5.5 3.0 8.0 
Guaiacol 24 4.5 4.0 6.0 3.0 7.0 
Syringaldazine 31 6.0 4.7 6.0 3.5 7.0 
KM (µM) 
ABTS 36 39 18 100 4 770 
2,6-Dimethoxyphenol 30 405 100 880 26 14 720 
Guaiacol 23 420 121 1600 4 30 000 
Syringaldazine 21 36 11 131 3 4307 
kcat (s-1)             
ABTS 12 24 050 5220 41 460 198 350 000 
2,6-Dimethoxyphenol 12 3680 815 6000 100 360 000 
Guaiacol 10 295 115 3960 90 10 800 
Syringaldazine 4 21 500 18 400 25 500 16 800 28 000 
n, number of observations; Q25, lower quartile; Q75, upper quartile. 
 
Substrates are oxidised close to the mononuclear site, and the electrons are 
transferred to the trinuclear site, where the molecular oxygen is reduced. Neither the 
electron transfer mechanism nor the oxygen reduction to 
water is fully understood. The reactio follows a radical 
type mechanism: substrates (phenols and aromatic or 
aliphatic amines) are oxidized by the T1 copper to 
produce radicals, which produce subsequently dimers, 
oligomers and polymers. The extracted electrons are 
probably transferred through a strongly conserved His-
Cys-His tripeptide motif to the T2/T3 site, where 
molecular oxygen is reduced to water [27] (Fig. 2.2).  
Kinetic data suggest a mechanism of reaction “two site 
ping-pong bi bi” type; in this mechanism the products are 
released before a new substrate molecule is ligated [29].  
 
Figure 2.2: Catalytic cycle of laccase.  
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Current information about laccase structures is based on the 3D structures of the five 
fungal laccases mentioned above: Coprinus cinereus 
(in a copper type-2- depleted form) [30], Trametes 
versicolor [28, 31], Pycnoporus cinnabarinus [32]], 
Melanocarpus albomyces [33] and Rigidoporus 
lignosus [34], the last four enzymes with a full 
complement of copper ions. Generally laccase is a 
monomer, organized in three sequentially arranged 
domains (Fig. 2.3) and the molecule has dimensions 
of about 65x55x45 Å3. Each of the three domains 
presents a similar β-barrel type architecture, related 
to that of small blue copper proteins such as azurin 
or plastocyanin. Domain 1 comprises two four-
stranded β-sheets and four 310-helices. Three of the 
310-helices are in connecting peptides between the 
β-strands, and one is in a segment between domain 
1 and 2. The second domain has one six-stranded 
and one five-stranded β-sheet, and like in domain 1, 
there are three 310-helices in peptides connecting 
individual β-strands and domains 1 and 3, respectively. A 310-helix between domains 
2 and 3 forms part of a 40-residue-long extended loop region. Finally, domain 3 
consists of a β-barrel formed by two five-stranded β-sheets and a two-stranded β-
sheets that, together with a α-helix and a β-turn, form the cavity in which the type-1 
copper is located. The trinuclear copper cluster (T2/T3) is embedded between 
domains 1 and 3 with both domains providing residues for the coordination of the 
coppers. The third domain has the highest helical content with one 310-helix and two 
α-helices located in the connecting regions between the strands of the different β-
sheets. Finally, at the C-terminal of domain 3, three sequentially arranged α-helices 
complete the fold. An α-helix formed by 13 residues at the C-terminal end is 
stabilized by a disulfide bridge to domain 1 (Cys-85–Cys-488), and a second disulfide 
bridge (Cys-117–Cys-205) connects domains 1 and 2. Both N-terminal and C-
terminal amino acids benefit from hydrogen bonding networks to the rest of the 
protein. Despite the amount of information on laccases as well as on other blue 
multicopper oxidases, neither the precise electron transfer pathway nor the details of 
dioxygen reduction in blue multicopper oxidases are fully understood [34]. 
 
The aim of the present work 
Evolutionary design approaches have devoted considerable attention in modifying 
native proteins. The generation of stable enzymes with improved or novel catalytic 
activities is a fascinating topic of modern protein biochemistry. This goal is relevant 
for basic research purposes as well as for applications in biotechnology. In addition, 
the search of new biocatalysts can have a major impact on the applications of 
enzymes in industrial processes. Enzyme engineering can, for instance, force 
enzymatic reactions to proceed in a desired direction, enhance their selectivity and 
their stability. Two different strategies can be applied to change enzymatic properties 
at wish. The first one is the directed evolution, which requires the gene (or genes) of 
interest, but does not require a detailed knowledge of structure and function of the 
coded protein. The second strategy is rational design, which is the planned redesign 
of the protein sequence by site-directed mutagenesis. In this case, the design of a 
new protein requires the knowledge of both structure and sequence as well as the 
Figure 2.3: Ribbon 
representation of T. versicolor
laccase X-ray structure. Domain 1 
is showed in red, domain 2 in 
green and domain 3 in bleu. 
Copper ions are show in vdW 
representation [31]. 
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mechanism of action of the enzyme. Selected residues are targeted for site-directed 
mutagenesis and after expression and purification the properties of the new enzymes 
are assessed by comparison with those of the native protein. Further residues may 
be targeted in further rounds of site-directed mutagenesis. This strategy, which has 
been applied extensively with variable success, depends on detailed structural and 
mechanistic information on the parent enzyme. Site-directed mutagenesis has been 
successful, for example, in redesigning the substrate specificity of a large number of 
common classes of enzymes, such as oxidoreductases (dehydrogenases and 
reductases) [35], hydrolases [36], transferases and restriction enzymes [37].  
The development of new bio-based processes using laccases requires deeper 
understanding of the structure/function relationship of native enzymes and the design 
of novel an improved molecules that are better suited for industrial applications.  
The aim of this part of my thesis was to model and to characterize molecular 
determinants in the mechanism of functioning of laccases form P. ostreatus. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rational mutagenesis of laccases POXA1b and POXC 
from Pleurotus ostreatus 
This section is aimed at the characterization of molecular determinants in the function 
of laccases, and at the development and characterization of new laccases using P. 
ostreatus isoenzymes (POXA1b and POXC) as templates for rational mutagenesis.  
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Results and Discussion 
 
Sequence alignment analysis  
  
Several laccase genes have been isolated and characterized, and in some cases, 
the sequences have been deposited in the appropriate gene register. The 
comparison of primary protein sequences of P. ostreatus laccases, whose structures 
are unknown, with any sequences of  basidiomycetes laccases whose structures are 
known, were performed using PRALINE program [38] (Fig. 2.4). As shown below, all 
fungal laccases contain several highly conserved ungapped regions, distributed 
almost throughout the entire length of the proteins. In particular, four ungapped 
sequence regions (1–4) that are clustered around the catalytic regions can be 
considered as the overall sequence fingerprint that can be used to identify the 
laccases, distinguishing them from the broader class of multi-copper oxidases.  
 
TvL1KYA         .GIGPVADLT ITNAAVSPDG F.SRQAVVVN GG...........TPGPLIT 
TvL1GYC         .AIGPAASLV VANAPVSPDG F.LRDAIVVN GV...........FPSPLIT 
POXC            .AIGPAGNMY IVNEDVSPDG F.ARSAVVAR SVPATDPTPATASIPGVLVQ 
POXA1b          ASIGPRGTLN IANKVIQPDG F.YRSTVLAG G...........SYPGPLIK 
RlG1V10         ATV..ALDLH ILNANLDPDG TGARSAVTAE G...........TTIAPLIT 
CcL1A65         QIVNSVDTMT LTNANVSPDG F.TRAGILVN G............VHGPLIR 
POXA3           ..ATKKLDFH IRNDVVSPDG F.ERRAITVN GI...........FPGTPVI 
 
                                             Region 1 
TvL1KYA         GNMGDRFQLN VIDNLTNHTM LKSTSIHWHG FFQKGTNWAD GPAFINQCPI 
TvL1GYC         GKKGDRFQLN VVDTLTNHTM LKSTSIHWHG FFQAGTNWAD GPAFVNQCPI 
POXC            GNKGDNFQLN VVNQLSDTTM LKTTSIHWHG FFQAGSSWAD GPAFVTQCPV 
POXA1b          GKTGDRFQIN VVNKLADTSM PVDTSIHWHG LFVKGHNWAD GPAMVTQCPI 
RlG1V10         GNIDDRFQIN VIDQLTDANM RRATSIHWHG FFQAGTTEMD GPAFVNQCPI 
CcL1A65         GGKNDNFELN VVNDLDNPTM LRPTSIHWHG LFQRGTNWAD GADGVNQCPI 
POXA3           LQKNDKVQIN TINELTDPGM RRSTSIHWHG LFQHKTSGMD GPSFVNQCPI 
               
                                        Region 2 
TvL1KYA         SSGHSFLYDF QVPDQAGTFW YHSHLSTQYC DGLRGPFVVY DPNDPAADLY 
TvL1GYC         ASGHSFLYDF HVPDQAGTFW YHSHLSTQYC DGLRGPFVVY DPKDPHASRY 
POXC            ASGDSFLYNF NVPDQAGTFW YHSHLSTQYC DGLRGPFVVY DPSDPHLSLY 
POXA1b          VPGHSFLYDF EVPDQAGTFW YHSHLGTQYC DGLRGPLVVY SKNDPHKRLY 
RlG1V10         IPNESFVYDF VVPGQAGTYW YHSHLSTQYC DGLRGAFVVY DPNDPHLSLY 
CcL1A65         SPGHAFLYKF TPAGHAGTFW YHSHFGTQYC DGLRGPMVIY DDNDPHAALY 
POXA3           PPNSTFLYDF DTAGQTGNYW YHSHLSTQYC DGLRGSFIVY DPNDPLKHLY 
 
 
TvL1KYA         DVDNDDTVIT LVDWYHVAAK ...L...GP. AFPLGADATL INGKGRSPST 
TvL1GYC         DVDNESTVIT LTDWYHTAAR ...L...GP. RFPLGADATL INGLGRSAST 
POXC            DIDNADTVIT LEDWYHIVAP ...Q...NA. AIPT.PDSTL INGKGRYAGG 
POXA1           DVDDESTVLT VGDWYHAPSL ...S...LT. GVP.HPDSTL FNGLGRSLNG 
RlG110          DVDDASTVIT IADWYHSLST ...VLFPNPN KAPPAPDTTL INGLGRNSAN 
CcLA65          DEDDENTIIT LADWYHIPAP ...SI..... QGAAQPDATL INGKGRYVGG 
POA3            DVDDESTIIT LADWYHDLAP HAQNQFFQTG SVPI.PDTGL INGVGRFKGG 
 
 
TvL1KYA         TTA.DLSVIS VTPGKRYRFR LVSLSCDPNY TFSIDGHNMT IIETDSINTA 
TvL1GYC         PTA.ALAVIN VQHGKRYRFR LVSISCDPNY TFSIDGHNLT VIEVDGINSQ 
POXC            PTS.PLAIIN VESNKRYRFR LVSMSCDPNF TFSIDGHSLL VIEADAVNIV 
POXA1b          PAS.PLYVMN VVKGKRYRIR LINTSCDSNY QFSIDGHTFT VIEADGENTQ 
RlG1V10         PSAGQLAVVS VQSGKRYRFR IVSTSCFPNY AFSIDGHRMT VIEVDGVSHQ 
CcL1A65         PAA.ELSIVN VEQGKKYRMR LISLSCDPNW QFSIDGHELT IIEVDGELTE 
POXA3           PLV.PYAVIN VEQGKRYRFR LIQISCRPFF TFSIDNHTFD AIEFDGIEHD 
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TvL1KYA         PLVVDSIQIF AAQRYSFVLE ANQAVDNYWI RANPNFGNVG ....FTGGIN 
TvL1GYC         PLLVDSIQIF AAQRYSFVLN ANQTVGNYWI RANPNFGTVG ....FAGGIN 
POXC            PITVDSIQIF AGQRYSFVLT ANQAVDNYWI RANPNLGSTG ....FVGGIN 
POXA1b          PLQVDQVQIF AGQRYSLVLN ANQAVGNYWI RANPNSGDPG ....FENQMN 
RlG1V10         PLTVDSLTIF AGQRYSVVVE ANQAVGNYWI RANPSNGRNG ....FTGGIN 
CcL1A65         PHTVDRLQIF TGQRYSFVLD ANQPVDNYWI RAQPNKGRNG LAGTFANGVN 
POXA3           PTPAQNIDIY AAQRASIIVH ANQTIDNYWI RAPLTGGNPA GNPNLDISLI 
 
 
TvL1KYA         SAILRYDGAA AVEPTTTQTT STAPLNEVNL HPLVATAVPG SPVAGGVDLA 
TvL1GYC         SAILRYQGAP VAEPTTTQTT SVIPLIETNL HPLARMPVPG SPTPGGVDKA 
POXC            SAILRYAGAT EDDPTTTSST ST.PLLETNL VPLENPGAPG PPVPGGADIN 
POXA1b          SAILRYKGAR SIDPTTPEQN ATNPLHEYNL RPLIKKPAPG KPFPGGADHN 
RlG1V10         SAIFRYQGAA VAEPTTSQNS GTA.LNEANL IPLINPGAPG NPVPGGADIN 
CcL1A65         SAILRYAGAA NADPTTSANP NPAQLNEADL HALIDPAAPG IPTPGAADVN 
POXA3           RAILRYKGAP AVEPTTVATT GGHKLNDAEM HPIAQEG.PG NLGTGPPDMA 
 
 
TvL1KYA         INMAFNFNGT NF..FINGAS FTPPTVPVLL QIISGAQNAQ DLLPSGSVYS 
TvL1GYC         LNLAFNFNGT NF..FINNAS FTPPTVPVLL QILSGAQTAQ DLLPAGSVYP 
POXC            INLAMAFDFT TFELTINGVP FLPPTAPVLL QILSGASTAA SLLPSGSIYE 
POXA1b          INLNFAFDPA TALFTANNHT FVPPTVPVLL QILSGTRDAH DLAPAGSIYD 
RlG1V10         LNLRIGRNAT TADFTINGAP FIPPTVPVLL QILSGVTNPN DLLPGGAVIS 
CcL1A65         LRFQLGFSGG RF..TINGTA YESPSVPTLL QIMSGAQSAN DLLPAGSVYE 
POXA3           ITLNIAQPNP PF.FDINGIS YLSPSVPVLL QMLSGARKPQ DFLPSEQVII 
 
                                       Region 3 
TvL1KYA         LPSNADIEIS FPATAAAPGA PHPFHLHGHA FAVVRSAGST VYNYDNPIFR 
TvL1GYC         LPAHSTIEIT LPATALAPGA PHPFHLHGHA FAVVRSAGST TYNYNDPIFR 
POXC            LEANKVVEIS MP..ALAVGG PHPFHLHGHT FDVIRSAGST TYNFDTPARR 
POXA1b          IKLGDVVEIT MP..ALVFAG PHPIHLHGHT FAVVRSAGSS TYNYENPVRR 
RlG1V10         LPANQVIEIS IPG.....GG NHPFHLHGHN FDVVRTPGSS VYNYVNPVRR 
CcL1A65         LPRNQVVELV VP..AGVLGG PHPFHLHGHA FSVVRSAGSS TYNFVNPVKR 
POXA3           LPANKLIEVS IPG.....AG AHPFHLHGHT FDIVRTSNSD VVNLVNPPRR 
                                                 Region 4 
TvL1KYA         DVVSTGTPAA GDNVTIRFRT DNPGPWFLHC HIDFHLEAGF AVVFAE...D 
TvL1GYC         DVVSTGTPAA GDNVTIRFQT DNPGPWFLHC HIDFHLEAGF AIVFAE...D 
POXC            DVVNTGT.GA NDNVTIRFVT DNPGPWFLHC HIDWHLEIGL AVVFAE...D 
POXA1b          DVVSIGDDPT .DNVTIRFVA DNAGPWFLHC HIDWHLDLGF AVVFAE...G 
RlG1V10         DVVSIG..GG GDNVTFRFVT DNPGPWFLHC HIDWHLEAGL AVVFAE...D 
CcL1A65         DVVSLGV..T GDEVTIRFVT DNPGPWFFHC HIEFHLMNGL AIVFAE...D 
POXA3           DVLPIN.... GGNTTFRFFS GNSGAWFLHC HIDWHLEAGL AVVFAERPAE 
 
 
TvL1KYA         IPDVASANPV PQAWSDLCPT YDARDPSDQ. .......... ..... 
TvL1GYC         VADVKAANPV PKAWSDLCPI YDGLSEANQ. .......... ..... 
POXC            VTSISA..P. PAAWDDLCPI YNALSDNDKG ......GIVP S.... 
POXA1b          VNQTAAANPV PEAWNNLCPI YNSSNPSKLL MGTNAIGRLP APLKA 
RlG1V10         IPNIPIANAI SPAWDDLCPK YNANNPDS.. ......GLA. ..... 
CcL1A65         MANTVDANNP PVEWAQLCEI YDDLPPEA.. ..TSIQ.TVV ..... 
POXA3           VNEGEQAQIV TQDWRTLCPA YDGLAPEFQ. .......... ..... 
 
Figure 2.4: Sequence alignment performed using the PRALINE program [38]. 
In purple are highlighted C-terminal regions of POXA1b and POXC laccases. The 
Asp residues highly conserved in all laccases are in blue and in red are shown the 
conserved histidine and cysteine.  
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C-terminus
Moreover, it is possible to observe that the copper-ligating residues in laccases are 
present in regions that are conserved across all analyzed laccases. A total of 11 
histidine residues and 1 cystein residues are conserved across all multi-copper 
oxidases and are thought to serve as the copper ligands.  
T. versicolor has a 459Leu-Glu-Ala461 sequence, typical for the high E0 laccases 
[39], whereas CcL has Leu-Met-Asn in the equivalent position. Glu-460 forms a 
hydrogen bond (H-bond) between and Ser-113, the latter being situated in the 
opposite domain 1. In particular, this serine residue is presumably forced by the H-
bond into an unfavourable main chain conformation. As a consequence of the 
attractive H-bond interaction, the whole helix, which contains His-458, is pulled 
toward domain 1, thereby increasing the Cu-N distance that seems to be responsible 
for the high E0 of this laccase (800 mV) [31] (Fig 2.5). In POXA1b the positions 
corresponding to Ser-113 and Glu-460 are taken by a glycine and an asparagine 
residue, respectively. These two residues cannot form an H-bond; a similar situation 
is found also in CcL (Coprinus cinereus laccase), a 
laccase with a redox potential of 550 mV [30].  
Moreover, an unusual protruding extension present 
in the C-terminal region, normally absent in other 
laccases, has been identified in POXC (six amino 
acids extra) and in POXA1b (sixteen amino acids 
extra).  
3D models of POXA1b and POXC (Fig. 2.6) 
were generated using T. versicolor laccase (PDB 
code 1GYC) that exhibits about 60% identity with 
both enzymes. To build the last sixteen residues 
of POXA1b, the coordinates of  the reported C-
terminal protruding extension (available only for 
the ascomycete laccase from M. albomyces PDB 
code 1GWO) were used [33]. Hakulinen et al. 
(2000) proposed that proteolytic cleavage of the C-terminus allows the opening of the 
tunnel for the entrance of the oxygen molecule and the exit of water [33]. Moreover, 
by replacing 11 amino acids at the C-terminus with a single cysteine residue, Gelo-
Pujic et al. (1999) managed to change the redox potential of the type-1 Cu of laccase 
from T. versicolor, produced in Pichia pastoris, [40].   
 
Figure 2.6: POXA1b (right) and POXC (left) models 
Figure 2.5: The hydrogen bond 
between Glu-460 and Ser-113 
which would subsequently cause an 
elongation of the Cu1-N (His-458) 
bond at the T1 site. The bond 
lengths are given in Angstroms. 
Image taken form [31]. 
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From all these observations it seems reasonable to suspect that C-terminus may play 
a key role in the function of the laccase enzyme. 
In order to investigate the role of the C-terminus in P. ostreatus laccases, site-
directed mutagenesis experiments have been performed in this region. Mutants of C-
terminal truncated laccases were designed: particularly POXA1b∆4 and POXA1b∆16 
and POXC∆6 have been created. 
It is widely accepted that in an evolutionarily related family of proteins fewer 
mutations occur in the functionally important residues. Many of the residues of 
catalytic regions are conserved in the analyzed laccases. The study of the 3D models 
of POXA1b and POXC has allowed for the identification of those residues 
constituting the catalytic site and involved in the interaction with substrates. The 
crystal structure of T. versicolor with 2,5-xylidine revealed two important residues for 
the interaction between the amino group of the reducing substrate and the enzyme: 
the first is a histidine residue (458) that also coordinates the T1 copper and acts as 
the primary electron acceptor from the substrate. This His458 is highly conserved 
among all laccases. The second, aspartate 206, is hydrogen bonded via the terminal 
oxygen of its side chain to the amino group of 2,5-xylidine. Asp206 appears relatively 
buried in the cavity, surrounded by hydrophobic residues which lie in a more exposed 
region [28]. The comparison of 3D models of POXA1b and POXC with POXA3 
models and docking with violuric acid, a phenolic substrate (Fig. 2.6), show that the 
arginine present in POXA3 could generate a repulsion that could lead to a decrease 
in the affinity for the substrate. 
 
 
Figure 2.6: Docking with violuric acid, the T1 Copper ion (yellow) and the violuric acid are 
shown in vdW representation. In licorice representation are highlighted the residues in close 
contact with the substrate for a) POXA1b, b) POXA3 and c) POXC. 
 
The Aspartic Acid, negatively charged, could stabilize the radicalic cation formed 
during the catalytic reaction; indeed the Arginine cannot stabilize the radicalic 
intermediate being positively charged. To characterize the molecular determinants 
involved in the interaction with substrates, mutants of POXA1b (D205R) and 
POXC(D210R) have been designed.  
The cDNAs of these two mutants have been introduced into the expression vectors 
by using host homologous recombination system in the yeast S. cerevisiae. 
 
POXC mutants: a qualitative evaluation 
The recombinant expression represents a good strategy in order to obtain sufficient 
recombinant protein for the characterization analyses. For the heterologous 
expression of POXC and of its mutants POXC∆6 and POXC (D210R), the expression 
vector pSAL4 has been used. This plasmid is characterized by the presence of the 
inducible promoter of metallothionein (CUP1) from S. cerevisiae and of the signal 
peptide of P. ostreatus.   
D 210 
 
D 205 
 
R 211 
 
a)                                    b)                               c)          
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Production of recombinant laccases was first assayed on plate using ABTS  (2,2'-
azino-bis(3-ethylbenzthiazoline-6-sulphonic acid)) as substrate as shown in Figure 
2.7. The purple halo obtained from the oxidation of substrate proves the presence of 
laccase activity. The marked difference of the halo intensity 
has led to the supposition that the mutants are less active 
than POXC. In particular, as shown in the Figure 2.7, mutant 
POXC∆6 turns out to be less active than the wild-type 
protein, while mutant POXC(D210R) seems to be inactive.  
However, when a similar analysis was conducted on 
liquid culture, activity production was too low to allow for the 
purification and subsequent characterization of these new 
laccases.  
 
Figure 2.7 : Plate assay of POXC wild-type and mutant laccases, using ABTS. (A) 
pSAL4; (B) pSAL4+poxC; (C) pSAL4+poxC(D210R); (D) pSAL4+poxC∆6. 
 
POXA1b 
In order to obtain heterologous expression of recombinant wild-type POXA1b and 
of its mutant proteins (POXA1b∆4, POXA1b∆16 and POXA1b(D205R)), the 
respective cDNAs were cloned in psal4 (see Methods) under the control of a strong 
promoter that is inducible by Copper. The yeast S. cerevisiae was transformed with 
each construct and cellular growth was obtained in selective medium (SD).  
Optical density (O.D.) and laccase activity production measurements were performed 
during the time course of the preparative culture. 
Mutants and wild-type expressing yeast growth 
curves did not differ significantly (data not shown). 
The analysis of the activity production has 
highlighted a higher specific activity production for 
the mutants POXA1b∆4 and POXA1b∆16 than for 
the wild-type protein; this could be attributed to a 
more effective enzymes production for these 
mutants. Instead the specific activity production of 
POXA1b(D205R) is comparable to that of the wild-
type protein (Fig 2.8).  
 
Purification of wild-type and mutant laccases 
Culture broths collected at the 6th growth day were used for laccase purifications. 
The recombinant POXA1b protein and the three mutants (POXA1b∆16, POXA1b∆4 
and POXA1b(D205R)) were purified by ammonium sulphate selective precipitation 
followed by gel filtration chromatography Superdex 75 prep grade as described in 
Materials and Methods. Similar amounts of total protein were obtained in all cases. 
The active fractions were pooled and concentrated on an Amicon PM-30 membrane.  
In Table II the yields after protein purification are given, obtained following the 
described procedures (see Materials and Methods). 
 
 
Figure 2.8: Laccases’ specific activity production in preparative cultures with ABTS; 
POXA1b (blue), POXA1b∆4 (red), POXA1b∆16 (green) and POXA1b(D205R) 
(purple). 
A 
B 
C 
D 
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Table II: Wild type and mutant proteins purification from S. cerevisiae cultures. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Laccase activity was recovered from supernatant of 100% ammonium sulphate precipitation 
 
Kinetic and catalytic parameters determination 
Some kinetic and catalytic parameters for three different substrates : 1) 2,2'-azino-
bis(3-ethylbenzthiazoline-6-sulphonic acid) (ABTS) at pH 3; 2) 2,6-dimethoxyphenol 
(DMP) at pH 5; 3) syringaldazine (SGZ) at pH 6) were determined; they are reported 
in Table III. 
 
 
ABTS structure 
 
 
 
DMP structure 
 
 
 
SGZ structure 
 
 
 
Purification 
step 
Total 
activity (U) 
Total 
protein (mg) 
Specific 
activity 
(U/mg) 
Recovery   
(U%) 
Purification 
fold 
 
PO
XA
1b
 
 
W
ild
-
ty
pe
 
 
 
Broth 
 
(NH4)2SO4* 
and SEC 
 
170 
 
100 
 
471.6 
 
5.8 
 
0.36 
 
17.2 
 
100 
 
59 
 
1 
 
47 
 
 
PO
XA
1b
∆
4 
 
 
Broth 
 
(NH4)2SO4* 
and SEC 
 
225 
 
135 
 
509.6 
 
6.3 
 
0.44 
 
21.6 
 
100 
 
60 
 
1 
 
49 
PO
XA
1b
∆
16
 
 
Broth 
 
(NH4)2SO4* 
and SEC 
 
107 
 
66 
 
527.4 
 
5.8 
 
0.20 
 
11.3 
 
100 
 
62 
 
1 
 
56 
PO
XA
1b
 
(D
20
5R
)  
Broth 
 
(NH4)2SO4* 
and SEC 
 
128 
 
82 
 
463.3 
 
9.33 
 
0.28 
 
8.8 
 
 
100 
 
64 
 
1 
 
31 
 
Laccases 
 
KM (mM) 
Specific 
activity 
(U/mg) 
Catalytic 
efficiency 
(U/mg*mM) 
                       ABTS 
Wild-type 0.16±0.01 37±1 231±2 
POXA1b∆4 0.11±0.01 23±2 209±3 
POXA1b∆16 0.14±0.02 9±1 63±1 
POXA1b (D205R) 0.33±0.05 9±1 27±1 
 DMP 
Wild-type 0.57±0.01 18±1 32±1 
POXA1b∆4 0.43±0.04 22±2 52±2 
POXA1b∆16 0.43±0.05 15±1 35±2 
POXA1b (D205R) 1.26±0.07 0.4±0.2 0.3±0.1 
 SGZ 
Wild-type 0.04±0.01 2,0±0.8 49±1 
POXA1b∆4 0.03±0.01 2,3±0.5 77±1 
POXA1b∆16 0.03±0.01 1,6±0.5 53±1 
POXA1b (D205R) N.D. ------- ------- 
Table III: Kinetic and catalytic parameters of wild 
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In general only slight differences have been observed in the Michaelis-Menten 
constant (KM), toward all substrates, of mutants POXA1b∆4, POXA1b∆16 compared 
with that of the wild-type protein. On the other hand, the KM value of POXA1b 
(D205R) toward ABTS and 2,6-DMP as substrates is 2-fold the one of the wild-type 
protein toward the same substrates. This reduced affinity for both substrates could be 
attributed to the introduced mutation. This mutation (Asp205 → Arg), located in the 
active site, could cause an alteration of the substrate-enzyme complex stabilization. 
This supports the hypothesis of a key role played by this aspartate residue in the 
interaction with the substrate. 
 
Effect of pH and Temperature on laccase activity 
The effect of pH on the activity of laccases towards DMP has been studied in the pH 
range 3,0÷6,4. In general, a bell-shaped profile of the 
activity as a function of pH has been observed for all the 
tested laccases. The optimum reaction pH of laccases 
for DMP oxidation was exceptionally high around pH 
values of 5.4-5.6.  
In particular, both POXA1b∆16 and POXA1b∆4 show 
a broader range of optimum pH than the wild-type 
protein. The mutant POXA1b(D205R) shows its 
maximum activity at lower value of pH  (~ 5) (Fig 
2.9).  
 
 
 
 
 
Optimal reaction temperature was determined by 
varying the reaction temperature, by 10°C increment s, in 
the range 20–70°C. 
POXA1b and the truncated mutants show their 
maximum activity at 60°C , whereas POXA1b 
(D205R) at lower temperature (50°C) ( Fig. 2.10).  
 
 
Stability as function of pH and temperature 
 
The 
laccase stability at different pH values 
has been examined by pre-incubating 
the enzymes at various pH values 
varying from 3.0 to 10.0 and by 
measuring the residual activity under 
standard assay conditions. 
As shown in Figure 2.11, the mutant 
POXA1b(D205R) exhibits a similar 
trend under all examined  
 
t 1
/2
t 1
/2
Figure 2.11: Stability of POXA1b (blue) and mutated laccases POXA1b∆4 
(red) and POXA1b∆16 (green) and POXA1b(D205R) (purple) at different pH 
values.  
Figure 2.9: Effect of pH on the 
activity of wild-type and mutated 
laccases. POXA1b (blue), 
POXA1b∆4 (red), POXA1b∆16 
(green) and POXA1b(D205R) 
(purple). 
 
Figure2.10: Effect of 
temperature on the activity 
of wild type and mutated 
laccases. POXA1b (blue), 
POXA1b∆4 (red), 
POXA1b∆16 (green) and 
POXA1b(D205R) (purple). 
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conditions, except for pH 3, which is an extreme condition for all the examined 
proteins. Therefore, the pH value seems not to influence strongly the protein stability. 
The generally low stability of POXA1b(D205R) could be attributed to a 
conformational change in the highly conserved region due the presence of the 
mutated residue with a positive charge (Asp-Arg). 
An unusual behavior was observed for the truncated mutants. In particular, at pH 5 
both show a t1/2 values more than 3-fold with respect to that of POXA1b, in addition at 
alkaline pH the mutants loose drastically the high characteristic stability of POXA1b 
(Figure 2.11 and Table IV). At neutral pH POXA1b and its mutants are similarly 
stable.  
These data suggest that C-terminal tail could be essential to stabilize the laccase 
structure at alkaline pH. In fact is well known that POXA1b is one of most stable 
laccases at this extreme pH and it is the only one that presents a protruding C-
terminal. 
Table IV: Protein half life values at different pH values 
 
 
 
 
 
 
 
 
 
 
 
 
In order to determine their thermostability, all enzymes were incubated at 60° at 
neutral pH and cooled down to room 
temperature prior to measuring the residual 
activity using ABTS as substrate.  
The enzymes appeared to be reasonably 
stable with respect to temperature; in 
particular POXA1b∆4 displays similar 
stability compared with that of wild type 
(Fig. 2.12 and Table V) whereas mutants 
POXA1b(D205R)  and POXA1b∆16 show a 
considerable loss of 
stability. 
                 
 
                     
                              Table V: Proteins half life values at 60°C 
 
 
 
 
 
 
 
                                                         t1/2 (Days) 
 
       Laccases 
pH3, 
McIlvaine 
buffer 
pH5, 
McIlvaine 
buffer 
pH7, 
NaP 
buffer 
pH7, 
Tris-HCl 
buffer 
pH10, 
Tris-HCl 
buffer 
Wild-type 0.9 2.8 8.1 7.1 29.6 
POXA1b∆4 1.9 13.3 8.1 7.2 9.3 
POXA1b∆16 3.9 13.3 6.0 9.2 6.0 
POXA1b(D205R) 3.0 7.2 6.0 6.0 8.2 
Laccases t1/2 (hours) 
Wild-type 4.5 
POXA1b∆4 5.1 
POXA1b∆16 3.3 
POXA1b (D205R) 3.3 
Figure 2.12: Stability of wild type and mutated laccases at 
60°C. POXA1b (blue), POXA1b ∆4 (red), POXA1b∆16 
(green) and POXA1b(D205R) (purple). 
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The obtained results have highlighted that POXA1b(D205R) shows not only 
diminished affinity for the substrate (Table III) but also loss of stability under all 
tested condition. These data suggest that the residue Asp205 is crucial for the affinity 
to the substrates, and that substitutions occurring in the catalytic region influence the 
stability of the protein, probably as a result of a rearrangement of the phenolic-
substrate cavity.  
The truncated mutants exhibit a small dissimilarity in the Michaelis-Menten 
constant (KM) but a considerable difference of stability with respect to the wild-type.  
The unusual C-terminal extension seems to be directly responsible for the 
extraordinary stability of POXA1b at alkaline pH. 
 
Materials and Methods 
 
Strains, media and plasmids 
The Escherichia coli strain Top 10 (F-mcrA D (mrr-hsdRMS-mcrBC) f80lacZDM15 
DlacX74 deoR recA1 araD139 D (ara-leu) 7697 galU galK rpsL (StrR) endA1 nupG) 
was used in all DNA manipulation. The medium used for growing E. coli was the rich 
medium Luria-Bertani (LB). Bacterial cultures were conducted at 37°C. Bacte rial cells 
competent to chemical transformation were obtained from cells grown on SOB 
medium. 
LB 
Bacto tryptone (Difco) 1% (w/v) 
Yeast extract (Difco) 0.5% (w/v) 
NaCl 1% (w/v) 
MgSO4 
Selective medium was supplemented with 100 µg ml-1 of ampicillin; solid medium 
contained agar 15% (w/v) (Difco). 
The S. cerevisiae strain used for heterologous expression of mutant laccases was 
W303-1A (MAT ade2-1, his3-11, 15, leu2-3, 112, trp1-1, ura3-1, can1-100). The 
medium used for growing wild-type S. cerevisiae was the rich medium  
YPD  
Yeast extract (Difco) 1% (w/v) 
Bacto tryptone (Difco) 2% (w/v) 
Glucose 2% (w/v) 
Cultures were conducted at 28°C. Solid medium conta ined 15% (w/v) of agar 
(Difco). Plasmids used for cloning procedures were pUC13 (Amersham Biosciences) 
for the gene poxc and pUC18 (Amersham Biosciences) for the gene poxa1b. 
 
Competent cells preparation and chemical transformation 
E. coli TOP 10 cells were picked up from a solid culture and grown in 5 ml of SOB 
medium at 37° C for 16 hours on a rotary shaker (25 0 rpm). The culture was then 
diluted 1:100 in the same medium and grown up to an optical density at 600 nm of 
0.6-0.7. Growth is stopped by putting the culture on ice for 20 min., and cells are 
sedimented by centrifugation at 3000 x g at 4°C for  10 min. Cells were washed twice 
by incubation with cold CaCl2 0.1 M for 20 min on ice. Cell pellet was then 
resuspended in CaCl2 0.1 M, and Glycerol 15% was added to the suspension. After 
vigorous mixing, the suspension was aliquoted and promptly frozen in dry-
ice/acetone bath. Competent cells was thawed and incubated with transforming DNA 
plasmid (up to 100 ng) for 30 min. on ice. Mixture was then shocked by incubation at 
42°C for 90 sec. and on ice for the same time. Cell s were spread on selective solid 
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LB medium after 1 hour incubation at 37 °C in LB me dium. 
 
Gel electrophoresis of DNA 
The PCR products were separated and analysed on agarose gel 1% (w/v). The 
electrophoresis was conducted in TAE (40 mM tris-acetate, 1mM EDTA pH 8) at 
100 V. To visualize DNA 0.5 µg ml-1 ethidium bromide was added to the agarose gel. 
This substance contains a planar group that intercalates between the stacked bases 
of DNA. DNA fragments were visualized with ultraviolet light (365 nm). 
PCR products and linear plasmid were extracted and purified from agarose gel 
with the kit Quiaex from Quiagen as specified by the manufacturer. 
 
Mini-preparation of plasmid DNA (alkaline lysis method) 
Bacterial cells grown on solid LB medium were inoculated at 37°C over night in 3 
ml of selective LB on a rotary shaker (250 r. p. m.). 1.5 ml of culture was centrifuged 
for 30 sec. at 13000 x g at room temperature. The cellular pellet was resuspended in 
100 µl of solution 1 (50 mM glucose, 10 mM EDTA, 25 mM Tris-HCl pH 8). 200 µl of 
solution 2 (0.2 N NaOH, 1% SDS) were added to the cellular suspension. After a 
vigorous shaking, the solution was incubated on ice for 5 min to denaturate the 
cellular proteins. Then 150 µl of  solution 3 (potassium acetate 5M pH 5.2, 
CH3COOH 11.5ml, H2O 28.5ml) were added, and the solution was incubated on ice 
for 5 min to allow the precipitation of genomic DNA. The suspension was centrifuged 
for 5 min at 13000 x g at room temperature. The supernatant, containing plasmidic 
DNA, was extracted with an equal volume of phenol: chloroform: isoamyl alcohol 
(25:24:1). The plasmidic DNA was then precipitated by adding 1ml of 100% EtOH at 
room temperature and rinsed with 200 µl of cold 70% EtOH. The plasmidic DNA was 
resuspended in 50 µl of TE 1X/RNase pH 8 (10 mM Tris HCl pH 8, 1 mM EDTA), 
RNAaseA (10 mg/ml) and incubated at 37°C for 30 min . 
 
Mini-preparation of plasmid DNA from S. cerevisiae [41] 
Yeast cells were grown in 3 ml of liquid SD medium at 28°C over night on a rotary 
shaker (150 r. p. m.). 1.5 ml of culture was harvested for 5 min. at 5000 x g at room 
temperature, and the pellet was re-suspended in 100 µl of cold STET (8% sucrose, 
50 mM Tris-HCl pH 8, 50 mM EDTA, 5% Triton X-100). Cells were lysated by adding 
0.2 g of 0.45 mm glass beads and vigorously vortexing. Following steps were: 
addition of another 100 µl of STET, briefly vortexing and incubation in a boiling water 
bath for 3 min. The suspension was then cooled on ice and centrifuged for 10 min. at 
5000 x g at 4°C. To 100 µl of the supernatant was added 2.5 M ammonium acetate: 
the sample was incubated at – 20°C for 1 h and cent rifuged for 10 min. at 12000 x g 
at 4°C. At this stage, residual chromosome DNA, lar ge RNA species, and the 
putative impurities which inhibit E. coli transformation are precipitated. To 100 µl of 
the supernatant were added 200 µl of ice-cold ethanol, and DNA was recovered by 
centrifugation. The pellet was washed with 70% ethanol and re-suspended in 20 µl of 
water. 10 µl of this solution were used to transform competent bacteria. 
 
Transformation and growth of S. cerevisiae 
S. cerevisiae transformation was done by using a lithium acetate protocol (Gietz et 
al. 1992). The cell pellet was then incubated in 1 ml of 0.1 M LiAc for 5 min at 30 °C. 
Cells were sedimented by centrifuging at 12000 x g for 5 sec, resuspended in a 
mixture containing: 240 µl of PEG (50% w/v), 36 µl LiAc 1 M, 25 µl SS-DNA (2.0 
mg/ml),  transforming DNA plasmid (up to 5 µg), 45 µl of H2O and incubated at 42° C 
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for 20 min. Cells were then centrifuged, resuspended in H2O, and spread on selective 
medium: plates were incubated inverted for 4 days at 28°C and checked for the 
development of green or orange colour.  
Experiments of homologous recombination were performed following the previous 
protocol and transforming the yeast cells with different ratios (1: 1 and 1:3) of 
linearized plasmid (1.5 µg) and mutated cDNA. 
Laccase production by transformants was first assayed on SD plates 
supplemented with 0.6 mM CuSO4 and 0.2 mM ABTS or 0.1 mM 2,6-DMP. Inocula 
grown on selective SD medium were used to seed flasks (250 ml) containing 50 ml of 
selective medium, starting from 0.5 OD600. Cultures were grown at 28°C on a rotary 
shaker at 150 rpm. Preparative culture was done in 1-l flasks containing 200 ml of 
medium. Culture aliquots (1 ml) were daily collected, centrifuged at 12000 g for 2 min 
at 4°C and assayed for optical density and laccase activity determination. Preparative 
cultures were performed in 1L flasks containing 200 ml of medium. 
Transformed yeast was grown in a selective medium: 
Selective medium SD 
Yeast nitrogen base w/o AA (Difco) 6.7 g/l 
Casaminoacids (Difco) 5 g/l 
Glucose 2% (w/v) 
Adenine 30 mg/l 
Tryptophane 40 mg/l 
Succinate buffer pH 5.3, 50 mM 
Copper sulphate 0,6 mM 
 
Homologous recombination  
Expression of mutated laccases in S. cerevisiae was performed taking advantage 
of the high level of homologous recombination in yeast, which makes in vivo 
approaches fast, efficient, and non-mutagenic. The optimal length of the homologous 
overhangs is usually over 100 bp on both 5' and 3' –ends. Overhangs can be 
generated by restriction of the cDNAs on the basis of the restriction map of the 
recombinants vectors. This study was performed starting from the most promising 
construct for both cDNAs, C-pSAL4 and B-pSAL4. Appropriate enzymes must cut the 
cDNA once or twice (if a deletion is wanted) in the latter case leaving at least 40 bp 
on each edge, and must not cut into the plasmid. The B-pSAL4 construct was cut 
with SmaI and BglII restriction enzymes leaving 155 bp at 5’-end and 475 bp at 3’-
end of the original poxa1b cDNA sequence. The overhangs will allow homologous 
recombination between the plasmid and the mutated cDNAs within the yeast cells 
allowing the closed plasmid to be maintained and propagated again. poxa1b cDNA 
was cloned in B-pSAL4 expression vector, digested with SmaI and BglII restriction 
enzymes, and poxc cDNA was cloned in C-pSAL4 expression vector, digested with 
AatII restriction enzyme, by using homologous recombination expression system of 
S. cerevisiae. 
Mutant poxa1b inserts were cotransformed with open plasmid that contains 
sequences homologous to the ends of the poxa1b cDNAs on both ends. Homologous 
recombination combines these to form complete plasmids. Negative control was 
performed transforming the yeast cells only with the B-pSAL4 open plasmid carrying 
poxa1b cDNA termini. Yeast cells, where homologous recombination between B-
pSAL4 plasmid and mutated cDNAs takes place will be able to grow on selective 
medium, since they carry out a closed plasmid.  
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Digestion with restriction enzymes 
The PCR products, the cloning vectors and cDNAs were hydrolysed with 
opportune restriction enzymes (Promega). The reactions were performed using 5U of 
enzyme each µg of DNA incubating at restriction nuclease optimum temperature for 2 
h and 30 min. 
 
Ligation of cDNA in a plasmid 
The ligation was performed with ligase from T4 bacteriophage (Boehringer 
Mannheim) at 16°C over night. A maximum of 100 ng o f plasmid was used for each 
reaction, and several molecular ratio plasmid: insert were tested (1:2, 1:3, 1:4), in a 
mix containing 1mM ATP, ligase buffer 1x and 1 U of enzyme. 
 
Polymerase chain reaction (PCR)  
To insert the cDNA of truncated poxc into pSAL4, was amplified in the presence of 
an upstream primer Fwpoxc using pUC13 containing poxc cDNA, as template, 
downstream primer Revpoxc∆6 contain restriction sites for EcoRI and HindIII have 
been used to remove last eighteen nucleotides. To gain poxa1b∆4 and poxa1b∆16, 
cDNAs of poxa1b were amplified in the presence of an upstream primer Fwpoxa1b, 
using pUC18 containing poxa1b cDNA, as template. Different downstream primers 
contain restriction sites for EcoRI and XhoI were used to remove last twelve and 
forty-eight nucleotides to obtain the two truncated genes (Table I). To obtain  poxa1b 
(D205R) and poxa1b (D210R), a point mutation was chosen so that the new codon 
fitted the peculiar S. cerevisiae codon. The PCR methodology has been used to gain 
a site-directed mutagenesis  
 
       Table VI: List of the primers used in amplification experiments. 
Fwpoxc   TTTGAATTCAAGCTTATGTTTCCAGGCGCACGG 
Revpoxc ∆6   TTATCTAGAAAGCTTTCATTGCGTTGTCG 
Fwpoxa1b   TGTTGCAGATCTTGTCGG 
Revpoxa1b ∆4   TAAGCATCCCTCGAGTCACGCAGGCAGACG 
Revpoxa1b ∆16   TAAGGATCCCTCGAGTCAGAGTTTCGATGGG      
Revmutpoxa1b(dr)   TTGATAGTTGGATCTGCAGGAAGT 
FwA(dr)   ACTTCCTGCAGATCCAACTATCAA 
Revmutpoxc(dr)   CGTGAAATTGGGTCTACAAGACAT 
Revpoxc(dr)   ATGTCTTGTAGACCCAATTTCACG 
 
Laccase purification from S. cerevisiae 
Culture media were harvested on the optimal laccase production day (6° day), 
cells were sedimented by centrifugation at 1600 g at 4°C for 15 min. Secreted 
proteins were filtered throw whatmann sheet. The sample was concentrated with 
Amicon stirred cells with ultrafiltration membranes with cut-off 30000 NMWLC. Then, 
most secreted proteins were precipitated by the addition of (NH4)2SO4 up to 100% 
saturation at 4°C and centrifuged at 10000 g for 40  min. The supernatant from 
ammonium sulphate precipitation was loaded onto a 26/60 Superdex 75 prep grade 
(Amersham Biosciences) column equilibrated with 0,15M NaCl 50 Mm Na-phosphate 
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buffer pH7. The active fractions were pooled and concentrated on an Amicon PM-30 
membrane. 
 
Enzymatic assay  
Culture aliquots (1 ml) were collected daily and cells were pelleted by 
centrifugation (12000 g for 2 min 4°C). Laccase act ivity in the culture supernatant 
was assayed at 25°C, monitoring the oxidation of AB TS spectrophotometrically  at 
420 nm (ε
420
= 36 mM
-1 
cm
-1): the assay mixture contained 2 mM ABTS, 0.1 M Na-
citrate buffer pH 3.0. Laccase activity towards 2,6-DMP was assayed in a mixture 
containing 1 mM 2,6-DMP and the McIlvaine’s citrate-phosphate buffer adjusted to 
pH 5.3. Oxidation product was followed by an absorbance increase at 477 nm (ε
477
= 
14.8 mM
-1 
cm
-1).  Laccase activity towards syringaldazyne (SGZ) was assayed in a 
mixture containing 0,1 mM SGZ and 0,2 M Na-phosphate buffer adjusted to pH 6.0. 
Oxidation of SGZ was followed by an absorbance increase at 526 nm (ε526= 6.5 x 
104 M-1 cm-1). 
Plate assay was performed on solid selective medium supplemented with enzyme 
substrate, 0.2 mM ABTS.  
 
Protein determination 
Protein concentration was determined allow Bradford method and  using 
commercial reactive of BioRad, with BSA (bovine serum albumin) as standard. 
 
 
Kinetic parameters determination  
Laccase activity in the culture supernatant was assayed utilizing increasing 
substrate concentrations (ABTS, 2,6-DMP and SGZ), until obtaining the complete 
saturation of the enzyme. KM values were estimated using the software GraphPad 
Prism, on a wide range of substrate concentrations. The values of ∆A/min according 
to values of concentration of the substrate have been brought back in diagram and 
have been determine the parameters to you of the curve of Michaelis-Menten, for 
that substrate.  
 
Effect of pH and temperature 
The effect of pH on laccase activity towards 2,6-DMP was measured using a 
McIlvaine’s citrate-phosphate buffer adjusted to different pH level in the range 3.0-
6.2. The effect of temperature on laccase activity was measured in the temperature 
range 20-70°C in 50 mM Na-phosphate buffer adjusted  to pH 7.0. 
 
Stability at pH and temperature 
Phenol oxidase stability at 60°C was measured in 50  mM Na-phosphate buffer 
adjusted to pH 7.0. Stability at pH values was measured using a McIlvaine’s citrate-
phosphate buffer adjusted at pH 3 and 5; 50 mM Na-phosphate buffer adjusted at pH 
7.0; Tris-HCl buffer adjusted at pH 7 and 10. 
 
Molecular Modelling and construction of enzyme substrate complexes 
The structure of POXA1b and POXC were obtained by homology modelling from 
the crystal structure of Trametes versicolor (1GYC pdb entry) [31], with which it 
shares about 60% sequence identity. It is well known that a sequence identity 
threshold for obtaining a reasonable model is 30% [42]. The last sixteen residues 
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were modelled using the coordinates of the C-terminus of the crystal structure of the 
M. albomyces laccase (1GWO pdb entry).  This choice is justified in consideration of 
the fact that the fold of the M.  albomyces and of the T. versicolor laccases is very 
similar, in particular in the C-terminal region the fold is almost identical. 3D models 
were generated using the SWISS-MODEL web server by means of the project mode 
option that allow to select the template and control the gap placement in the 
alignment [43].  
To obtain a reasonable starting model of the complexes  between laccases 
models and violuric acid, the crystal structure of  T. versicolor laccase complexed 
with an arylamide [28] (PDB code: 1KYA) was chosen as template based on the high 
sequence identity (60%) of proteins. The backbone and the common residues of 
laccase models were superimposed onto that of T. versicolor laccase. The violuric 
acid was also superimposed onto the 2,5-xylidine and then was merged with 
structure of each models. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Development of new laccases by directed evolution: functional 
and computational analyses 
 
The aim of this section is to integrate the results of the generated mutants by Festa 
G. (PhD thesis 2006, University of Naples “Federico II”) through structural and 
computational analyses  to investigate some of the reasons, at a molecular level, for 
the enhanced activity shown by specific mutations. 
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Development of new laccases by directed evolution: functional and 
computational analyses  
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Sannia1 
1Dipartimento di Chimica Organica e Biochimica, Università di Napoli “Federico II”, 
Complesso Universitario Monte S. Angelo, via Cintia, 80126 Napoli, Italy 
2King’s College, Randall Division of Cell and Molecular Biophysics, New Hunt's House, SE1 
1UL, London, U.K. 
 
Materials and Methods 
Strains, media and plasmids.  
The Escherichia coli strain Top 10 (F-mcrA D (mrrhsdRMS- mcrBC) f80lacZDM15 
DlacX74 deoR recA1araD139 D (ara-leu) 7697 galU galK rpsL (StrR) endA1 nupG) 
was used in all DNA manipulations. E. coli was grown in Luria–Bertani (LB) medium 
(in g l−1: 10 bacto tryptone, 10 NaCl, 5 yeast extract), supplemented, when required, 
with 100 µg ml−1 of ampicillin. 
The S. cerevisiae strain used for heterologous expression was W303-1A (MATade2-
1, his3-11, 15, leu2-3, 112, trp1-1, ura3-1, can1-100). The plasmids used for S. 
cerevisiae expression were C-pSAL4 and B-pSAL4,15 both carrying URA3 gene for 
auxotrophic selection. S. cerevisiae was grown on a selective medium [6.7 g l−1 yeast 
nitrogen base without amino acids and ammonium sulfate, 5 g l−1 casamino acids, 30 
mg l−1 adenine, 40 mg l−1 tryptophan, 50mM succinate buffer (pH 5.3), 20 g l−1 
glucose].  
The K. lactis strain used for heterologous expression was CMK5 (a thr lys pgi1 adh3 
adh1URA3 adh2URA3).16 The plasmids used for K. lactis expression were pYCps 
and pYA1bps.15 K. lactis was grown in YPPG medium (in g l−1: 10 yeast extract, 40 
bacto tryptone, 20 glucose), supplemented with ethanol (0.5%), CuSO4 (0.1mM) and 
when required, with 100 µg ml−1 of geneticin G418. 
Random mutagenesis.  
DNA shuffling of poxc and poxA1b cDNAs was performed using the protocol 
described by Van der Veen17 based on the shuffling method described by Zhao and 
Arnold18. The cDNAs were fragmented using the following restriction enzymes: NlaIV 
and TaqI for poxc and HinfI and TaqI for poxa1b.  Fragmented genes were subjected 
to a PCR without primer (PCR1) using Taq DNA polymerase (Promega Corp., 
Madison, Wisconsin, USA). Cycling parameters were 40 cycles of 95°C for 1 min, 
55°C for 1 min, 72°C for 1min + 5 s/cycle. Aliquots  of the product of PCR1 were used 
as template in a conventional PCR with four different combination of primers: 
1)POXA1bfw and POXa1brev; 2) POXA1bfw and POXCrev; 3) POXCfw and 
POXA1Brev; 4) POXCfw and POXCrev (Table I). Cycling parameters were 10 cycles 
of 95°C for 30 s, 55°C for 30 s, 72°C for 45 s and 14 cycles of 95°C for 30 s, 55°C for 
30 s, 72°C for 45 s + 5 s/cycle. The full-length sh uffled cDNAs were purified using 
QIAquick Gel Extraction Kit (Qiagen GmbH, Hilden, Germany).  
Random mutations were introduced with low, medium and high frequency of 
mutation, into the POXC and POXA1b encoding cDNAs using GeneMorphTM PCR 
Mutagenesis Kit (Stratagene, La Jolla, CA, USA). Error-Prone PCR was performed 
with primers POXA1bfw and POXA1brev for poxa1b and POXCfw and POXCrev for 
poxc (Table I).   
Construction of a mutant library.  
The cDNAs resulting from DNA shuffling were digested EcoRI/HindIII and ligated in 
B-pSAL4 vector digested with EcoRI/HindIII restriction enzymes. The cDNA resulting 
from EP-PCR on poxa1b cDNA were cloned in B-pSAL4 expression vector, digested 
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with SmaI and BglII restriction enzymes, by using homologous recombination 
expression system of S. cerevisiae. The cDNA resulting from EP-PCR on poxc cDNA 
were cloned in C-pSAL4 expression vector, digested with AatII restriction enzyme, by 
using homologous recombination expression system of S. cerevisiae. Yeast 
transformation was done by using the lithium acetate protocol.19 The cells were 
spread on selective medium supplemented with 0.6 mM CuSO4 and 0.2 mM ABTS 
and the plates incubated upside down for 4 days at 28°C.  
Library screening. 
Single clones grown on plate were picked and transferred into 96-well plates 
containing 30 µl of selective medium per well. Plates were incubated at 28°C, 250 
rpm for 24 h. After 24 h 130 µl of  selective medium was added to each well and the 
plates were incubated at 28°C, 250 rpm for 24 h. Th irty microliters of each culture 
was transferred to a new 96-well plate to measure the OD600 value. The plates were 
then centrifuged for 10 min at 1,500×g, 4°C and a suitable volume of supernatant 
was transferred to a new 96-well plate to perform laccase assay. Phenol oxidase 
activity was assayed at 25°C using 2 mM 2,2’-azino- bis(3-ethylbenzothiazoline-6-
sulfonic acid) (ABTS) in 0.1 M sodium citrate buffer, pH 3.0. Oxidation of ABTS was 
followed by absorbance increase at 420 nm (ε 36,000 M-1 cm-1), using Benchmark 
Plus microplate spectrophotometer (BioRad, Hercules, CA, USA). Enzyme activity 
was expressed in international units (U). 
Cultures in shaken flasks were also performed. Pre-cultures (10 ml) were grown on 
selective medium at 28° C on a rotary shaker (150 r pm). A volume of suspension 
sufficient to reach a final OD600 value of 0.5 was then used to inoculate 250 ml 
Erlenmeyer flasks containing 50 ml of selective medium and cells were then grown 
on a rotary shaker. Optical density and laccase activity determination were daily 
assayed.  
DNA sequencing.  
Sequencing by dideoxy chain-termination method was performed by the Primm 
Sequencing Service (Naples, Italy) using specific oligonucleotide primers. 
Protein purification.  
Preparative cultures were performed in 1L flasks containing 200 ml of medium. 
Culture media were harvested on the optimal laccase production day, cells were 
sedimented by centrifugation at 1600×g at 4°C for 1 5 min. Secreted proteins were 
filtered throw Whatmann sheet. The sample was concentrated using Amicon stirred 
cells with PM30 ultrafiltration membranes (Millipore, Billerica, MA, USA).  Most 
secreted proteins were precipitated by the addition of (NH4)2SO4 up to 100% 
saturation at 4°C and centrifuged at 10000×g for 40  min. The supernatant from 
ammonium sulphate precipitation (containing laccases) was loaded onto a 26/60 
Superdex 75 prep grade (GE healthcare Bio-Sciences, AB, Uppsala, Sweden) 
column equilibrated with 0.15M NaCl, 50 mM Na-phosphate buffer pH7. The active 
fractions were pooled and concentrated on an Amicon PM-30 membrane. 
Protein concentrations were determined using the BioRad Protein Assay (BioRad), 
with bovine serum albumine as standard. 
Laccase activity assays. 
Phenol oxidase activity was assayed at 25°C using A BTS, 2,6-dimethoxyphenol 
(DMP), and syringaldazine (SGZ) as substrates as follows. (a) The assay mixture 
contained 2 mM ABTS and 0.1 M sodium citrate buffer, pH 3.0. Oxidation of ABTS 
was followed by absorbance increase at 420 nm (ε420 36,000 M-1 cm-1). (b) The assay 
mixture contained 1 mM DMP and the citrate-phosphate buffer was  adjusted to pH 
5. Oxidation of DMP was followed by an absorbance increase at 477 nm (ε477 14,800 
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M-1 cm-1). (c) The assay mixture contained 0.5 mM syringaldazine (dissolved in 
ethanol) and 50 mM phosphate buffer, pH 6. Oxidation of syringaldazine was 
followed by an absorbance increase at 525 nm (ε525 65,000 M-1 cm-1). Enzyme 
activity was expressed in IU. 
Phenol oxidase activity as a function of pH was measured at room temperature using 
citrate-phosphate buffer adjusted to different pH levels in the range 3.0–6.2. Stability 
at pH values was measured using citrate-phosphate buffer adjusted at pH 3, 5 and 
7.0, Tris-HCl buffer was adjusted at pH 10.  
Molecular Modelling and Molecular Dynamics simulations. 
The structure of POXA1b was obtained by homology modelling from the crystal 
structure of Trametes versicolor (1GYC pdb entry), with which it shares 60% 
sequence identity. It is well known that a sequence identity threshold for obtaining a 
reasonable model is 30%.20 The last sixteen residues of POXA1b were modelled 
using the coordinates of the corresponding residues at the C-terminus of the crystal 
structure of the Melanocarpus albomyces laccase (1GWO pdb entry). This choice is 
justified in consideration of the fact that the fold of the M.  albomyces and of the T. 
versicolor laccases is very similar, in particular in the C-terminal region the fold is 
almost identical. As can be seen in Fig. S2, the additional tail can be easily allocated 
onto this region of the protein  
3D model and in silico mutants were generated using the SWISS-MODEL web server 
by means of the project mode option that allow to select the template and control the 
gap placement in the alignment.21    
Refinement of the models has been performed by Molecular Dynamics simulations. 
22,23
 
Simulations on the wild type POXA1b and on the in silico generated mutants 1M9B 
and 3M7C were performed with the GROMACS package24 using the GROMOS96 
force field.25 The systems were neutralized and were solvated in a box of  SPC 
water,26 in a solution of 50mM NaCl (17 Na+ and 18 Cl-). All the simulated boxes 
contained about 16,500 water molecules. Simulations were carried out at a constant 
temperature of 300K. The Berendsen algorithm was applied for the temperature and 
pressure coupling.27 After a first steepest descent energy minimization with positional 
restraints on the solute, the LINCS algorithm was used to constrain the bonds28 and 
to carry out an initial 200ps simulation with the positions of the solute atoms 
restrained by a force constant of 3000 kJ/(mol*nm2) in order to let the water diffuse 
around the molecule and to equilibrate. The particle mesh Ewald method (PME)29 
was used for the calculation of electrostatic contribution to non bonded interactions 
(grid spacing of 0.12 nm). The systems were run for 4 ns each and the last 500 ps of 
simulations were used for the energy decomposition analysis. GROMACS package 
and self-written programs have been used for the analysis of the data. Images were 
produced with visual molecular dynamics (VMD 1.8.5.).30  
 
Results 
Construction and screening of mutant laccase libraries  
Random mutations were introduced into poxa1b and poxc cDNAs by error-prone 
PCR. Three different PCR conditions were used to yield low, medium and high 
average of mutation frequency (0÷3 mut/kbases, 3÷7 mut/kbases and more than 
7mut/kbases respectively). Moreover a shuffled cDNA library was constructed by 
poxc and poxa1b cDNA digestion followed by in vitro recombination.  
Both K. lactis and S. cerevisiae were used as expression systems for P. ostreatus 
laccases heterologous production, although K. lactis is a much more effective 
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producer than S. cerevisiae15.  Mutated cDNAs were introduced into the expression 
vectors by using host homologous recombination system. When K. lactis was used, 
several mutants (70%) able to grow on selective medium but unable to express any 
laccase activity were obtained. Even if K. lactis was transformed with the open vector 
(control) several clones growing on selective medium were obtained.  As a fact, the 
budding yeast K. lactis, in contrast to S. cerevisiae, is known to show, variable, but 
generally low, gene targeting efficiency.31,32  Therefore random recombination of the 
resistance gene could explain the achievement of clones able to grow on selective 
medium even if transformed with the open vector.  On this basis S. cerevisiae was 
preferred to K. lactis as host for expressing laccase mutated cDNAs, because no 
problem related to low gene targeting efficiency was faced in this case.  1100 
transformants were obtained by S. cerevisiae transformation with pSAL4 vector and 
mutated cDNAs. Thirty-eight mutants were selected, by multiwell plate screening, 
having activity towards ABTS higher than that of the controls (yeasts expressing wild 
type POXC and POXA1b). The second screening, performed following growth rate 
and activity production of the clones in multiwell plates for three days, allowed us to 
confirm positivity of only 7 mutants out of the 38 previous isolated. These seven 
clones were then grown in shaken flasks for six days for further analyses. The mutant 
1M9B, originated from error-prone PCR with medium frequency using poxa1b as 
template, showed significantly higher activity (about 50% increase) than that of wild 
type POXA1b (Fig. 1).   
1m9b cDNA was used as template for a second round of error-prone PCR at low and 
medium frequency of mutation. A second generation library of 1200 clones was 
obtained and screened using the same procedure described before. Three mutants, 
1L2B, 1M10B and 3M7C, were selected showing 70÷100% activity increase with 
respect to 1M9B towards the substrate ABTS. Figure 1 shows the laccase specific 
production (mU/OD) of these clones compared to that of the wild type. 
Characterization of mutated and wild type laccases. 
The recombinant POXA1b protein and the four selected mutants (1M9B, 1L2B, 
1M10B and 3M7C) were partially purified by ammonium sulphate selective 
precipitation followed by gel filtration chromatography as described in Materials and 
Methods. Similar amounts of total proteins were obtained in all the cases. 
A non phenolic substrate, ABTS, and two phenolic substrates, SGZ and DMP, were 
used to analyse the catalytic properties of mutants compared with those of the wild 
type enzyme (Table II).  All the mutants show Michaelis constant (KM) values similar 
to that of wild type towards ABTS, while their affinity towards DMP is higher than that 
of wild type protein. Only 1L2B mutant showed KM value towards SGZ lower than that 
of the wild type.  The specific activities of the mutants towards ABTS increased 
(1.7÷2.5-fold) with respect to the wild type protein.  1L2B, 1M10B and 3M7C mutants 
also exhibit 1.5 to 1.8-fold specific activity increase towards DMP, while no significant 
changes of their ability in SGZ oxidization were detected.  On the other hand 1M9B 
shows a specific activity value lower than that of wild type protein towards both 
phenolic substrates.  
All proteins, including the wild type, are fully active in the temperature range 40-65°C.  
The effect of pH on the activity of recombinant laccases towards DMP was studied in 
the pH range 3.0÷6.2 (Fig. 2). All the laccases tested show maximum activity at pH 
value of ~4.2, but all the mutants are slightly more responsive to the pH increase 
above pH 4.4 value than the wild type protein.  
Stability of the enzymes with respect to temperature at neutral pH was studied. All 
the mutants, except for 1M9B, showed higher half life at 60°C with respect to the wild 
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type recombinant protein (Table III). Stability of the laccases in different buffers and 
pH values was also studied at room temperature (Table III). Mutant 1M9B is the less 
stable one in all the analyzed conditions, while 1L2B, 1M10B and 3M7C show t1/2 
values similar or higher than that of the wild type protein.  
Sequence analysis of the mutants led to the identification of nucleotide substitutions 
producing the mutations reported in brackets: 1M9B (L112F); 1L2B 
(L112F/N248Y/N261K/V350I); 1M10B (L112F/K37Q/K51N); 3M7C (L112F/P494T).  
In silico structural analyses 
Models of the 3D structure of POXA1b was constructed by homology modelling from 
the crystal structure of the Trametes versicolor  laccase 33 as a template, with which 
shares about 60% of identity (alignment of the two proteins is shown in Figure S1). 
The last sixteen residues [L498-A513] of POXA1b were modelled using the 
coordinates of the corresponding residues at the C-terminus of the Melanocarpus 
albomyces laccase,34 the only laccase whose structure has been resolved showing a 
protruding C-terminus, like POXA1b. Inspection of the sequence alignments of the 
laccase family revealed that the position 112, which is mutated in all the isolated 
mutants, follows the consensus region 98-111 (WYHSH) where the histidine residues 
coordinating type 3 copper ions are located. In position 112 there is a generally 
conserved leucine in all laccases from basidiomycetes, while a phenylalanine seems 
to be conserved in laccase sequences from ascomycetes. POXA1b 3D model shows 
that residue 112 is located in the channel through which the solvent has access to 
the oxygen-reducing T3 site (Fig. 3). 
As far as 1L2B mutant is concerning, position 248 is quite variable in laccase 
sequences: N, E, D, T, H or K residues can occur at this position but a Y residue is 
never found. Differently, the two residues N261 and V350 are highly conserved and 
no laccase showing a K residue in position 261 or an I residue in position 350 can be 
found. From the 3D model we can observe that position 261 is located in a loop 
potentially interacting with the substrate (Fig. 3).35  
The two additional substitutions observed in 1M10B mutant occur in positions 37 and 
51 that are generally conserved in laccase sequences and occupied by amidic 
residues. 
The last mutant analysed, 3M7C, presents only one substitution (P494T) besides the 
L112F. Position 494 is located in a variable and mobile loop at the C-terminus that, in 
accordance with modelling data, forms a sort of “plug” blocking the channel through 
which the solvent has access to type-3 copper sites (Fig. 3B).  
Molecular Dynamics simulations  
Two selected mutants generated by the first and second screenings, 1M9B and 
3M7C respectively, have been further characterized and compared to the wild type 
POXA1b by means of MD simulations. The simulations performed on the three 
systems have reached equilibration after 500 ps as can be seen from the RMSD 
(Root Mean Square Deviation) of the Cα atoms as a function of time (Fig. 4A). The 
molecules are stable under the simulated conditions and converge to similar energy 
values as shown in Table IV.  
The major differences between the systems are highlighted by the analysis of their 
flexibility exhibited in solution. POXA1b is mostly rigid and does not show any major 
concerted motion. In Figure 4 (panels B and C) is shown the plot which represents 
the difference of the Root Mean Square Fluctuation (∆-RMSF) of the Cα atoms 
between POXA1b and the 1M9B and 3M7, respectively. 1M9B experiences a large 
fluctuation in the region 300-380 while 3M7C shows a highest fluctuation in the 
regions 265-270 and 330-350. 
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The Principal Component Analysis (PCA) method is used to reduce the complexity of 
the data obtained by MD simulations and to highlight the principal components 
responsible of the observed motion. The total motion is decomposed in the principal 
components to which an eigenvector and an eigenvalue are associated. We decided 
to present only the analysis of the first two eigenvectors because they account more 
than 45% of the total amount of the motion of the systems. 
1M9B shows a rearrangement of the residues in proximity of the F112 giving rise to 
an increased flexibility of the entire subdomain. On the other hand 3M7C presents 
more rigidity in that subdomain, while showing a major rearrangement in proximity of 
the substrate binding region (Fig. 5), leading to a more accessible T1 copper site. 
Nevertheless the secondary structure remains generally preserved for both mutants 
and the fold is not affected by the enhanced flexibility.  
A significant effect generated by the mutations is observed in the permeability to 
water of the T2/T3 channel.  Residue F112 is located at the entrance of the channel 
and its steric hindrance affects the passage of water molecules towards the trinuclear 
copper cluster.  A detailed analysis of the water molecules in close contact with the 
channel residues has been performed, in terms of both their distances from these 
residues and their residence times in the channel (Fig. 6). Moreover, snapshots from 
the MD simulations (Fig. 6 D, E, F) show the location of the water molecules in the 
channel T2/T3 for each system. In the case of 1M9B an average of five water 
molecules are trapped near the cluster, while only three were found in the POXA1b 
channel (Fig. 6 A, B).  The F112 residue of 1M9B acts as a gating residue for the 
water molecules preventing their exit from the channel as shown in Figure 6E.  A 
different behaviour was observed in 3M7C because the mutation P494T affects the 
position of F112. As a consequence, F112 is not obstructing the channel anymore, 
and although an average of three water molecules remain locked in the channel, as 
for POXA1b (Fig. 6 A, C), more water molecules can enter in the cavity remaining 
coordinated for a shorter time then in 1M9B and POXA1b. 
 
Discussion 
In this paper we describe the in vitro evolution of laccases from Pleurotus ostreatus 
leading to enzymes endowed with increased specific activity towards phenolic and 
non-phenolic substrates as well as increased stability. We performed random 
mutagenesis experiments on poxc and poxa1b cDNAs, using Error Prone PCR (EP-
PCR), the most frequently used non recombinative method, and DNA shuffling, the 
most traditional among recombinative methods.36 Applications of these methods 
resulted in collections of shuffled and mutated sequences with low, medium and high 
frequency. After transformation into Saccharomyces cerevisiae, a first library of 1100 
clones was obtained and screened.  
As far as DNA shuffling is concerning, only 40% of the clones were able to express 
active laccases.  Although the most significant changes in enzyme functions can be 
created using the DNA shuffling technique, cDNAs coding for inactive proteins are 
mainly produced during “gene reconstruction” confirming the idea that this 
methodology leads to frequent damages of essential structural protein components.36 
As a matter of fact, no “better performing” variants were obtained from DNA shuffling.  
When EP-PCR was used, the number of mutants able to produce laccase activity 
drastically dropped down, increasing the frequency of mutation (90, 30 and 10% for 
low, medium and high frequency of mutation, respectively). This is consistent with the 
generally accepted concept that the probability of discovering beneficial mutations 
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decreases at high mutation rate, since the majority of random mutations are either 
neutral or deleterious.37  
The POXA1b mutant named 1M9B selected from the screening of the first library, is 
more active towards ABTS but less stable with respect to POXA1b in all the analyzed 
conditions. To elucidate the role played by the single mutation L112F of 1M9B, MD 
simulations were performed and compared to those of POXA1b.  The analyses show 
a movement of the subdomain around position 112 as a consequence of a 
conformational rearrangement due to the presence of the bulkier residue of 
phenylalanine. Moreover a larger number of water molecules in the T2/T3 channel 
has been observed for 1M9B (Fig. 6B). These data could suggest an increased 
affinity of this mutant towards oxygen molecules, thus justifying its improved specific 
activity.  
This mutant has been used as a template for a second round of EP-PCR. From the 
library of 1200 clones obtained, three mutants have been selected (1L2B, 1M10B 
and 3M7C), partially purified, and characterised. These mutants, besides improved 
activity towards phenolic and non-phenolic substrates, exhibit higher stability then 
POXA1b in all the conditions analysed. Therefore the additional substitutions found in 
the second generation mutants, compensate for the destabilizing effect of the L112F 
substitution either in a correlated or uncorrelated fashion.  
The most stable and active mutant, 3M7C, presents, besides L112F, only one 
substitution (P494T) that has to be responsible of its improved performances. The 
position 494 is located in the C-terminal loop that has already been ascertained to 
affect the function of fungal laccases. Hakulinen et al.34 proposed that a 
conformational change in the C-terminus allows opening of the tunnel for the 
entrance of oxygen molecule and the exit of water in the laccase from the 
Ascomycete Melanocarpus albomyces. Moreover Gelo-Pujic et al.38 have changed 
the redox potential of the type-1 Cu of laccase from Trametes versicolor, produced in 
Pichia pastoris, replacing 11 amino acids at the C-terminus with a single Cys residue.  
During the MD simulations of all the studied systems, POXA1b, 1M9B and 3M7C, 
high flexibility of the C termini and involvement of these regions to direct water 
molecules towards the T2/T3 channel has been observed.  
Furthermore MD simulations of the 3M7C mutant protein reveal a lower flexibility of 
the subdomain around position 112 with respect to that of 1M9B, this could be 
related to the recovered stability of 3M7C. On the other hand, an increased mobility 
of loops forming the reducing substrate binding site has been observed leading to 
higher accessibility of water molecules to the T1 copper site and possibly leading to 
an increased activity of the enzyme. 
Laccases are proteins with highly conserved and functionally essential wide regions; 
therefore not many positions can be mutated without loosing activity. The identified 
serendipitous mutations, although not directly involved in catalysis, have been proved 
to influence the efficiency and the stability of the enzyme. Our mutagenesis 
experiment has led to more efficient enzymes and to an increase of our knowledge of 
the structure-function relationships of this class of enzymes. 
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Table I: List of the primers used in amplification 
experiments. Nucleotides in bold are complementary to the 
laccase cDNA sequences. Nucleotides in italics are recognized by 
restriction enzymes. 
Primer Nucleotide sequences Ann. T 
POXA1bfw ATAAAAGCTTGAATTCATGGCGGTTGCATTCG 90°C 
POXA1brev TAAGGATCCAAGCTTTTATAATCATGCTTC 82°C 
POXCfw TTTAAGCTTGAATTCATGTTTCCAGGCGCACGG 96°C 
POXCrev AAAAGAATTCAAGCTTTTAAGAAGTAGGAATAAGAAG 94°C 
 
 
 
Table II. Catalytic parameters of the wild type protein and the selected mutants. 
 ABTS DMP SGZ 
Laccases 
KM 
(mM) 
Specific 
activity 
(U mg-1) 
Catalytic 
efficiency 
(U mg-1mM-1) 
KM 
(mM) 
Specific 
activity 
(U mg-1) 
Catalytic 
efficiency 
(U mg-1mM-1) 
KM 
(mM) 
Specific 
activity 
(U mg-1) 
Catalytic 
efficiency 
(U mg-1mM-1) 
Wild type 0,085±0.007 183±1 2153±15 0,54±0.02 187±1 346±7 0,048±0.006 23.2±0.8 483±2 
1M9B 0,067±0.005 315±1 4701±23 0,36±0.02 168±1 467±9 0,038±0.007 9,3±0.5 245±1 
1L2B 0,107±0.009 420±2 3925±71 0,31±0.01 295±2 952±19 0,025±0.004 24,3±0.5 972±2 
1M10B 0,100±0.009 421±2 4210±76 0,35±0.01 281±1 803±8 0,040±0.006 24,3±0.6 607±2 
3M7C 0,077±0.009 454±2 5896±106 0,24±0.01 337±2 1404±28 0,055±0.011 26,9±0.9 489±5 
 
 
 
 
 
Table III Half-life of the wild type protein and the 
selected mutants at different pH values and at 
60°C.  
Laccases t½ (days) t1/2 (hours) 
  pH3 pH5 pH7 pH10 60°C, pH7 
Wild type  0.9 2.8 7.6 29.6 2.2 
1M9B  0.6 1.9 3.6 24.0 1.7 
1L2B  1.1 4.0 6.3 34.4 2.8 
1M10B  1.1 3.9 8.6 44.6 2.5 
3M7C  1.5 5.7 13.5 31.9 3.1 
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TABLE IV: Energy decomposition analysis of MD simulations 
The first and the last 500 ps of simulations were used for the energy decomposition analysis. 
 
 
 
 
POXA1b 
Energy (kJ mol-1) E initial Energy (kJ mol-1) E final 
Protein-Protein (El) -38626 Protein-Protein (El) -38819 
Protein-Protein (LJ) -18286 Protein-Protein (LJ) -18822 
Protein-Protein (total) -56912 Protein-Protein (total) -57641 
Protein-Solvent (total) -32272 Protein-Solvent (total) -32101 
1M9B 
Energy (kJ mol-1) E initial Energy (kJ mol-1) E final 
Protein-Protein (El) -38502 Protein-Protein (El) -38790 
Protein-Protein (LJ) -18235 Protein-Protein (LJ) -18735 
Protein-Protein (total) -56737 Protein-Protein (total) -57525 
Protein-Solvent (total) -32325 Protein-Solvent (total) -32544 
3M7C 
Energy (kJ mol-1) E initial Energy (kJ mol-1) E final 
Protein-Protein (El) -38805 Protein-Protein (El) -38873 
Protein-Protein (LJ) -18414 Protein-Protein (LJ) -18681 
Protein-Protein (total) -57219 Protein-Protein (total) -57554 
Protein-Solvent (total) -31650 Protein-Solvent (total) -32730 
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LEGEND AND FIGURES 
 
 
Figure 1. Time course of laccase activity in the 
extracellular medium of S. cerevisiae cultures 
producing wild-type and mutated enzymes (♦ wild 
type POXA1b; ־ 1M9B; ▲3M7C; ■ 1M10B; □ 
1L2B) 
 
 
 
 
 
Figure 2. Effect of pH on the activity of wild type 
and mutated laccases towards DMP as substrate 
(♦ wild type POXA1b; ־ 1M9B; ▲3M7C; ■ 1M10B; 
□ 1L2B) 
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Figure 3 (A) and (B) show ribbon representation of POXA1b model.  The mutated residues 
are in licorice rendering (L112 blue; N248, N261, V350 orange; K37, K51 gray; 
P494 red). Trinuclear coppers and T1 copper are highlighted in van der Waals 
representation (purple and yellow respectively). 
 
 
 
 
 
Figure 4. Panel A: RMSD of the Cα atoms from their 
initial coordinates as a function of time, for the three 
simulated systems. Black line, POXA1b; light gray, 
1M9B; gray, 3M7C.  
Panels B and C: ∆RMSF of 1M9B (B) and 3M7C (C) 
of the Cα atoms with respect to their average position 
along their entire simulation compared to the Cα 
atoms from the simulation of POXA1b. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. ‘Sausage’ plots representing the motions observed during simulation trajectories 
along the first eigenvector. (A) POXA1b; (B) 1M9B; (C) 3M7C. 
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Figure 6. Analysis 
of the water 
molecules that are 
in close contact 
(0.4 nm) with the 
channel residues 
of (A) POXA1b, 
(B) 1M9B and (C) 
3M7C during the 
entire simulated 
time. Ribbon 
representation of 
models, POXA1b 
(D), 1M9B (E) and 
3M7C (F). Cu ions 
(T2/T3 cluster in 
green and T1 in 
magenta) and the 
water molecules 
in close contact 
with the channel 
of T2/T3 cluster 
are shown in van 
der Waals 
rendering. In 
panel D residue 
L112 is 
highlighted, in 
panel E residue 
F112, and in 
panel F both 
residues F112 
and T494 are 
shown.   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Structural characterization of heterodimeric laccases 
from Pleurotus ostreatus 
 
The aim of this section was to generate the models of the two isoforms of POXA3 
generated by a different sliced and to analyses the sequence diversity of POXA3 with 
respect to other laccases. 
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Introduction: Malaria as a public health problem 
Still in the 21st century malaria represent one of the major threats for health in many 
parts of the world. It is estimated that between 400 and 900 million febrile episodes 
occur every year only for African children, with a minimum of 750,000 deaths 
(probably up to 3 million). Sub-Saharan Africa is the most affected region in the 
world, but malaria is also a serious problem in several other places, such as South-
East Asia, Oceania, Middle East and Latin America. Although transmission of the 
parasites via the Anopheles mosquitoes was discovered in 1880 by Charles Alphonse Louis Laveran, 
malaria remains a serious public-health problem for roughly 40% of the world's 
population.Human malaria is caused by one of four parasites: Plasmodium 
falciparum, P. vivax, P. malariae, and P. ovale. Of these the two species P. 
falciparum and P. vivax are the most widely distributed, both causing a vast amount 
of human pain.  All trials to develop a new vaccine have paid considerably more 
attention to P. falciparum than to P. vivax. This is because P. falciparum is more 
virulent and is responsible for more than 95% of the malaria deaths worldwide; it is 
also the only human malaria parasite resistant to chloroquine and other antimalarial 
drugs. Humans are the intermediate hosts in the plasmodia life cycle and are usually 
infected when bitten by a female mosquito carrying the parasite. Transmission can 
be prevented by the use of repellents and insecticides, but nevertheless according to 
World Health Organization (WHO) the prevalence of malaria is on the rise.  
The cost of malaria is particularly heavy for developing countries, because the 
economic effects of preventing and treating malaria are very high and present 
therefore a large burden on the health budget. The economics of developing new 
pharmaceuticals for different diseases, including malaria, are such that there is a 
great disparity between the public health importance of the disease and the amount 
of resources invested in developing new cures. 
Due to the lack of cost-effective treatments and the emergence of resistance, a 
malaria vaccine is likely to be crucial in reducing both the morbidity and the mortality 
of this disease. Drug resistance has been implicated in the increase of malaria to 
new areas and re-emergence of malaria in areas where the disease had been 
eliminated. Population movement has introduced resistant parasites to areas 
previously free of drug resistance. In general, resistance appears to happen through 
spontaneous mutations that confer reduced sensitivity to a class of drugs. For some 
drugs, only a single point mutation is necessary to give resistance, while for other 
drugs, multiple mutations appear to be required. Vaccination is a successful method 
of disease control. Many are the factors that make the development of a malaria 
vaccine an incredibly difficult challenge. In fact it is the complex biology of the life 
cycle of the parasite that impedes vaccine development. The malaria parasite 
presents thousands of antigens to the human immune system that vary throughout its 
life cycle. Identifying those that may prove to be vaccine targets is complicated. Most 
vaccines are targeted at individual stages of the malaria life cycle, although it is likely 
that only the development of a multistage vaccine will offer complete protection to 
both visitors to, and residents of, a malaria-endemic area. Even if the development of 
a vaccine would result successful, other issues such as cost, distribution, education, 
and compliance will have to be addressed.  
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Life cycle of the malaria parasite 
  
The life cycle of the malaria parasite is very complex. It can be divided into two 
distinct stages, one occurring in the mosquito host and another in the human host 
(Fig 3.1). The sporozoites are 
transmitted into the subcutaneous tissue 
via the bite of infected mosquito. The 
sporozoites enter hepatocytes shortly 
after inoculation into the blood 
circulation; it’s demonstrated that this 
process involves surface proteins of the 
sporozoites and host cell surface 
molecule. Once inside hepatocytes, the 
sporozoites develop into schizonts 
containing thousands of merozoites. The 
merozoites are released into the blood 
flowing through the sinusoids of the liver 
after 6–15 days, depending on the 
Plasmodium spp. The circulating 
merozoites infect erythrocytes within a 
few seconds and begin the asexual 
cycle. Within the erythrocyte, the parasite passes through the ring and trophozoite 
stages before the production of the erythrocytic schizont; each mature schizont 
produced about 20 merozoites. The merozoites are released after 48 h, with the 
destruction of the erythrocyte, and are then free to infect further cells. Finally some 
merozoites within the erythrocytes differentiate into immature gametocytes. On biting 
an infected intermediate host the mosquito ingests blood containing the parasite and 
the normally asexually dividing bloodstream forms (merozoites) die. The 
gametocytes are stimulated and the sexual stage of the cycle then continues in the 
mosquito. 
  
Figure 3.1: Schematic illustration of the life 
cycle of malaria parasites. Image from [1] 
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The aim of the present work 
Vaccination is a useful tool to control the malaria disease. Studies of the immune 
response to the malaria parasite in humans and in animal models have provided a 
wealth of information on possible protective mechanisms. Antigen identification have 
produced many candidates for subunit vaccines [2]. Single proteins or peptides have 
been shown to be at least in part protective when are used in vaccination studies [3]. 
While different antigens epitopes have been identified, such as those recognized by 
neutralizing antibodies [4], multiple target vaccine have not yet been successfully 
designed.Proteins on the surface of the merozoite are excellent targets for 
development of vaccines against malaria, because they are exposed to antibody. 
One of these proteins is the merozoite surface protein 1 (MSP-1). Its C-terminal 
sequence is the target of protective antibody for this reason it can be  a candidate for 
vaccine development. This protein is involved in the initial recognition of the 
erythrocyte; MSP-1 interacts with spectrin on the cytoplasmic face of the erythrocyte 
membrane [5].  
Initially MSP-1 is synthesized as a large (~200 kDa) precursor during intracellular 
merozoite development; it is present on the surface of the released merozoite and it’s 
anchored by a glycosyl phosphatidyl inositol tail [6]. 
MSP-1 is cleaved by proteases in two processing 
steps; the second step releases the bulk of the 
protein from the surface and goes to completion 
during successful red blood cell invasion. The 
precursor is first cleaved into four pieces in a primary 
processing step that occurs on merozoite release; at 
some point between merozoite release and 
completion of erythrocyte invasion, the membrane-
bound component (MSP-142) of this surface complex 
is further cleaved at a single site to form two 
fragments, MSP-133 and MSP-119 (secondary 
processing). After that the majority of the complex 
is being shed from the parasite surface, leaving 
only a 96 amino acid residue C-terminal fragment 
(MSP-119) onto the surface of the parasite. The 
structure of P. falciparum MSP119 has been 
solved by NMR [7] (Fig 3.2), and its homologues from Plasmodium cynomolgi [8] and 
Plasmodium knowlesi [9] have been solved by X-ray crystallography. 
This fragment is composed of two epidermal growth factor (EGF)-like motifs. Each 
domain presents a major stretch of antiparallel β-sheet containing the third and fourth 
Cys residues of each domain, as expected for an EGF-like fold, as well as an 
additional minor antiparallel β-sheet at the C-terminal end of domain-1, similar to 
almost all EGF family members. The C-terminal fragment of MSP1, is a leading 
candidate antigen for development of a vaccine against the blood stages of the 
malaria parasite. In fact, antibodies binding to the C-terminus of P. falciparum MSP-1
 
can inhibit both the processing and erythrocyte invasion (inhibitory antibodies). On 
the other hand, other antibodies that bind to either the C-terminal sequence or 
elsewhere in the molecule are termed blocking antibodies, because on binding 
prevent the binding of the inhibitory antibodies [10, 11].  
Figure 3.2: Ribbon representation 
of MSP119. Domain 1 is shown in 
blue and in magenta the domain 2. 
In licorice representation in 
highlighted the cysteines forming 
disulphide bridge [7].  
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Morgan et al [12, 13] have 
studied by TROSY NMR 
experiments, the complexes 
of P. falciparum MSP119 with 
Fab fragments from three 
monoclonal antibodies. Two 
of them, Fab12.8 and 
Fab12.10, have shown a  
parasite-inhibitory activity in 
vitro [6]. NMR epitope 
mapping of Fab12.8 and 
Fab12.10 have shown a 
close relationship between 
binding sites for the two 
inhibitory antibodies, distinct 
from the location of the non-
inhibitory antibody. Cross-
saturation mapping of the 
epitopes recognized by 
these two parasite inhibitory 
anti-MSP119 monoclonal 
antibodies exhibited a 
remarkable degree of 
similarity. The most affected 
residues identified for each 
of the inhibitory monoclonal 
antibodies cluster in a region 
located on one of the two broad surfaces of the disk-shaped MSP119 molecule (Fig 
3.3). From these experiments, six residues have been individuated for antibody 12.10 
(Gln 6, Cys 7, Asn 15-Cys 18) and five residues for antibody 12.8 (Gln 14-Cys 18). 
These results are in good agreement with previous binding studies showing that  
antibody 12.8 bounded to MSP119 domain 1 by itself, while binding of mAb 12.10 
required the presence of both domains [14]. This was consistent with the greater 
degree of perturbation of domain 2 residues by Fab12.10. It is important to remember 
that, one limitation of this method is that it provides no information on contacts to the 
side chains of antigen residues. In order to investigate this further, we decided to 
model the antibody structures, and to investigate protein-protein interactions with the 
antigen (including potential side chain contacts) by means of docking calculations 
and therefore to refine the resulting complexes from the docking procedure by 
performing Molecular Dynamic simulations. Moreover ,in order to validate the 
docking procedure the X-ray structure of a Fab complex formed with PfMSP119 [15] 
was used as test case. 
Figure 3.3: Interface residues for the P. falciparum 
MSP119-Fab complexes mapped by TROSY NMR. The 
residues most sensitive to cross-saturation are shown by 
colour (panel A and D) and residues that experienced a 
large chemical shift perturbation are displayed in colour  
(panels C and F) on the antigen surface. The amide 
groups of the same residues are also highlighted on the 
ribbon diagram (B and E) [11]. 
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Introduction: Restriction factors of retroviruses replication 
The latest data published from UNAIDS/WHO in the 2006 estimated that 39.5 million 
people are living with Human immunodeficiency virus (HIV). There were 4.3 million 
new infections in 2006 with 2.8 million (65%) of these occurring in sub-Saharan 
Africa and important increases in Eastern Europe and Central Asia, where there are 
some indications that infection rates have increased by more than 50% since 2004. 
More than 2.9 million people died of AIDS only in 2006. With numbers such as these, 
AIDS has attracted vast resources from governments, universities, and industry the 
world over for the single purpose of controlling, preventing, and ultimately curing the 
disease.  
At the present time, no effective cure or vaccine exists for AIDS. However, due to the 
relative success of Highly Active Antiretroviral therapy (HAART) survival of infected 
individuals has dramatically improved in the last 20 years. Untreated, AIDS 
compromises the body's immune system, and a wide variety of opportunistic 
infections do occur. These AIDS-related complications span the gamut of diseases 
and include bacterial, viral, protozoal and fungal infections. Current therapy regimens 
target the viral reverse transcriptase, protease, envelope and most recently integrase 
proteins, most commonly as a combination treatment of three different drugs. 
Nonetheless, due to the high level of genetic drift of HIV, (multi)-drug resistance is 
increasingly interfering with current therapies. Hence there is a continuous demand 
for novel drugs that target HIV. 
In recent years it has emerged that the cells of the immune system themselves 
exhibit a defence mechanism against infection by viruses that occur in the cell. The 
proteins that mediate this innate immunity (restriction factors) are the human proteins 
APOBEC3F and APOBEC3G (A3F/G). These proteins act as a barrier to the 
replication of viruses that replicate via a single-stranded minus strand DNA 
intermediate. Unfortunately, the antiviral function of A3G is neutralized in by the HIV-
encoded protein VIF (Virus Infectivity Factor) [2, 3]. In the absence of VIF, the host 
anti-retroviral factor A3G is packaged into the HIV-1 virus and down-regulates HIV-1 
infection by causing extensive lethal deoxycytosine-to-deoxyuracil mutation in the 
newly synthesized HIV-1 negative-strand DNA [4].  
VIF binds specifically A3F/G and then targeting it for ubiquitination and degradation 
[4], prevents efficiently A3F/G being packed into the newly synthesized virus so that 
the virus remains infectious.  The interaction of Vif with the A3F/G proteins clearly 
represents an attractive target for the development of new anti_HIV drugs, as 
therapeutic disruption of this interaction is thought to leave the virus defenceless 
against the antiviral action of A3F/G.  
 
The APOBEC family of cellular deaminases 
Cytidine deaminases are a large superfamily of enzymes involved in pathways such 
as lipoprotein metabolism, pyrimidine salvage pathways, antibody diversification and 
the maintenance of genome integrity. This class of enzymes converts cytosine to 
uracil by deamination. Cytidine deaminases (CDA), are characterized by a Zinc-
binding catalytic domain with a specific consensus sequence H-X-E-X23-28-P-C-X2-4-C 
(X indicates any amino acid) [6]. In Humans the APOBEC sub-family is constituted 
by: Activation Induced Deaminase (AID), Apolipoprotein B mRNA editing catalytic 
subunit 1 (APOBEC1 or A1), APOBEC2 (A2), APOBEC3A–APOBEC3H (A3A–A3H) 
and APOBEC4 (Fig 4.1). APOBEC1 is the founding member of this APOBEC family 
of proteins, having first beeen demonstrated to edit specifically a single codon in the 
mRNA of Apolipoprotein B, leading to the synthesis of a truncated protein. Other 
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members have been named after APOBEC1, although it subsequently emerged that 
these enzymes edit DNA rather than RNA and they do not affect Apoliprotein 
metabolism. For example, the family member AID hypermutates the variable region 
of immunoglobulin genes leading to antibody diversification. 
More recently, A3F/G were shown to hypermutate single stranded DNA replication 
intermediates of viruses and mobile genetic elements such as retrotransposons. 
Human APOBEC3F and 3G are expressed in CD4+ B cells that are the natural target 
of HIV [4, 7, 8]. The substrate specificities of A3F and 
A3G are finely different, the former preferring to edit 
the cytidine in a TC dinucleotide context to TU, while 
A3G shows a preference for CC dinucleotides [4, 9].  
To manage this, the A3G/F protein must be 
packaged into virions and transferred to target cells 
but in the presence of VIF this process is inhibited; 
VIF connects A3G/F to an E3 ubiquitin ligase, 
inducing polyubiquitylation and the subsequent  
proteasomal degradation [1]. 
 
Structures of APOBEC proteins 
The crystal structures of several nucleotide CDAs have been reported showing a 
canonical mixed β-sheet motif with the catalytic 
residues exposed in α-helices at one side of the 
sheet (Fig. 4.2 A). However, these structures are 
of limited use as templates for the modelling of 
APOBEC proteins, as they are considerably 
smaller due to their function of binding a nucleotide 
rather than polynucleotide substrate.  
Tetramerisation of nucleotide CDAs shows one 
monomer interacting with other two forming a 
square arrangement of subunits (Fig. 4.2). The 
interaction between each monomer is through 
residues of the α-helices (Fig. 4.2 B-C) [13, 14].  
Recently, the crystal structure of A2 has been 
reported [12], representing the first structure of an 
APOBEC protein and showing considerable differences with the nucleotide CDAs. 
Currently, the function of A2 is unknown, although it has been shown to be 
specifically expressed in skeletal and cardiac muscle.   A2 is a tetrameric protein of 
224 amino acids, each monomer contains one CDA domain that consists of five beta-
sheet flanked by six helices (Fig 4.3 A). The major difference between the structure 
of A2 and other CDAs is in the mode of multimerization, which in A2 is linear rather 
than globular. The A2 dimer is formed by joining two β-sheets sideways in order to 
form one wide β-sheet.  
Figure 4.1: (a) Domain organization of human APOBEC proteins. In red the cytidine 
deaminase motifs in each protein are highlighted; the consensus amino acid sequence is 
shown below. (b) The cytidine deamination reaction catalysed by APOBEC enzymes. 
Image from [1]. 
Figure 4.2: Ribbon representation 
of crystal structure of CDD1: (A) 
monomer;  (B) dimer; (C) tetramer. 
 
A B 
C 
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Many hydrogen bonds are formed between 
the β-sheet of monomers through main-
chain atoms, providing the main bonding 
force between the two monomers (Fig 4.3 
B). The way in which the two monomers 
interact is extremely different from the ones 
previously described. A2 tetramer is formed 
by two dimers that interact through head-to-
head interactions (Fig 4.3 C).  
There are large number of  contacts 
between the two dimers formed 
indiscriminately by hydrophobic, aliphatic 
and charged residues [12]. 
 
 
 
Aim of the work 
The HIV-1 VIF protein by interacting with A3G/F at the time of virus production 
induces the elimination of these two important restriction factors proteins, and lifts the 
barrier to viral replication that they cause. The therapeutic blockade of the Vif-A3F/G 
interaction represents an ideal goal for rational drug design. The disruption of the Vif-
A3F/G interaction would leave the virus defenceless, leading A3F/G to inhibit reverse 
transcription and to hypermutate the viral genome, stopping this way viral replication.  
Recently, Huthoff and Malim from the Division of Virology, King’s College London 
have published a prediction of a possible structural arrangement for APOBEC protein 
domains based on secondary structure predictions [15] and have performed alanine 
scanning mutagenesis experiments to identify the domain  within A3G that mediate 
sensitivity to HIV-1 Vif [16]. In particular, these data have allowed identifying a three-
amino acid motif Asp128-Pro129-Asp130 (D-P-D) in A3G that is essential for the 
interaction with VIF to occur. In addition, a motif of four amino acids YYFW (Tyr124-
Tyr125-Phe126-Trp127), immediately precedent to the D-P-D motif was identified to be 
essential for virion packaging [16].  
It is worth mentioning that A3F does not contain the D-P-D motif, suggesting the 
presence of different sites of interaction between VIF and A3F.  
In order to define the molecular determinants playing a role in the interactions 
between A3F/G and VIF, an interdisciplinary approach has been used to analyze the 
structure-function characteristics of these complexes comprising the following 
techniques: molecular genetics, biochemistry, viral evolution, virus infectivity and 
computational analysis. My contribution in this interdisciplinary effort has focused on 
the generation of molecular models by means of computational techniques. The 
resulting models assist rationalization of the results obtained from the other 
methodologies. 
Figure 4.3: Ribbon representation of 
crystal structure of A2: (A) monomer;  
(B) dimer; (C) tetramer. 
A B 
C 
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Results and Discussion 
 
Dimerization models: 
• Human APOBEC3G 
 
In order to model the 3D structure of APOBEC3G, the structure of A2 was chosen as 
template. Recently a model of monomeric A3G has been also based on this structure 
[17]. The difference with our approach is that we extended the modelling to include 
the dimeric structure of A3G. While A2 is a tetramer formed by four monomers of 224 
amino acids with one CDA domain, A3G contains two CDA domains within a 384mer 
polypeptide (Figure 4.1). Hence we reason that an A3G monomer is equivalent to the 
dimeric structure of A2 and that dimerization of A3G mimics tetramerization of A2. 
The amino-terminal CDA domain (N-CDA) of A3G is required for viral encapsidation 
but not cytosine deamination, whereas the cytosine deamination is performed by the 
C-CDA domain. [18-20].  
To build up the dimer model, each CDA domain of A3G was modelled with respect to 
the corresponding monomer in the A2 structure.  
 The dimerization of A3G can be modelled in two possible ways: i) dimerization 
mediated by N-terminal CDA domains, termed head-to-head (HHd) and ii) 
dimerization mediated by C-terminal CDA domains, termed tail-to-tail (TTd). Each of 
this possible dimerization models has been considered as equally probable in a first 
instance. A2 shows 33% of identity on average with each CDA domain of A3G. In 
Figure 4.3 the alignment performed with the program praline [21] of the sequence of 
A2 dimer with the entire sequence of A3G is shown.  
 
A2   SGGGMIVTGERLPANFFKFQFRNVEYSSGRNKTFLCYVVEAQGKGGQVQASRGYLEDEHA 
A3G  MKPHFRNTVERMYRDTFSYNFYNRPILSRRNTVWLCYEVKTKGPSRPPLDAKIFRGQVYS 
 
A2   A---AHAEEAFFNTILPA--FDPALRYNVTWYVSSSPCAACADRIIKTLSKTKNLRLLIL 
A3G  EL-KYHPEMRFFHWFSKWRKLHRDQEYEVTWYISWSPCTKCTRDMATFLAEDPKVTLTIF 
 
A2   VGRLFMWEEPEIQAALKKLKE----AGCKLRIMKPQDFEYVWQNFVEQEEGESKAFQPWE 
A3G  VARLYYFWDPDYQEALRSLCQKRDGPRATMKIMNYDEFQHCWSKFVYS---QRELFEPWN 
 
A2   DIQENFLYYEEKLADILK*GSGGGMIVTGERLPANFFKFQFRNVEYSSGRNKTFLCYVVEA 
A3G  NLPKYYILLHIMLGEILR*----------HSMDPPTFTFNFNNEPWVRGRHETYLCYEVER 
 
A2   QGKGGQVQASRGYLEDE--HA-------AAHAEEAFFNTILPA-FDPALRYNVTWYVSSS 
A3G   MHNDTWVLLNQRRGFLCNQAPHKHGFLEGRHAELCFLDVIPFWKLDLDQDYRVTCFTSWS 
 
A2   PCAACADRIIKTLSKTKNLRLLILVGRLFMWEEPEIQAALKKLKEAGCKLRIMKPQDFEY 
A3G   PCFSCAQEMAKFISKNKHVSLCIFTARIYDDQ-GRCQEGLRTLAEAGAKISIMTYSEFKH 
 
A2   VWQNFVEQEEGESKAFQPWEDIQENFLYYEEKLADILK 
A3G   CWDTFVDH---QGCPFQPWDGLDEHSQDLSGRLRAILQ 
 
Figure 4.4: Alignment between two monomers of A2 and a whole sequence of A3G. The 
stars indicate the beginning of monomeric unit of A2. The residues of N-CDA and C-CDA are 
displayed in red and in green, respectively.  
 
In the C-CDA domain there is an insertion of twelve amino acids that precedes the 
histidine of the catalytic site, while this insertion is shorter in the N-CDA domain. 
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To build the models we used the program MODELLER [25]. This software generates 
hundred models for each query (see methods) and performs an optimization of the 
generated models with respect to a defined objective function. 
The selected models were chosen on the basis of the objective function’s score and 
on the basis of the rotamers adopted by the catalytic residues (H-X-E-X23-28-P-C-X2-4-
C) coordinating the Zn ions. Two ‘families’ of dimerization modes were generated by 
MODELLER: a bent and an elongated model (FIG 4.5).  
Figure 4.5: The elongate (left )and bent (right) modelobtained from  HHd dimerization 
 
The major difference between the 3D models and the template is in the extended 
loop in the C-CDA that connects strand β2 and helix2 (see Fig.4.5), corresponding to 
an insertion in the sequence. The TTd bent model brings these two loops too close to 
each other, presenting a distance between the two monomers of 13 Å, whereas the 
same distance is of 30 Å for the HHd model. The two loops are exposed to the 
solvent in the HHd bent model.   
The fold adopted from TTd bent model disposes the CDA domains at the hinge 
region of the dimer, making them not easily accessible to ssDNA/RNA, and not in an 
ideal disposition for the enzyme activity. To characterize the interaction surface, the 
program POPScomp was used [22, 23] to detect the residues that were hidden from 
the dimerization (Table I and Table II). POPScomp calculates the solvent accessible 
surface area (SASA) of each residue before and after the formation of a complex. In 
this case a difference of SASA of 15 Å2 was used as cut-off to select the residues 
buried upon complex formation.  
The elongated dimers present only few contacts between the two monomers. In 
particular, the residues involved in the HHd comprise the two motifs essential for the 
interaction with VIF (128DPD139) and for virion packaging (124YYFW127); on the 
contrary the TTd exposes these residues and places the C-CDA at the interface. In 
the bent dimerization models there are 
a larger number of contacts in the 
hinge region between the two 
monomers (Table II). Also in this case 
in the HHd the DPD and YYTW motifs 
are at the dimer interface. To better 
characterise the dimer interface, site-
directed mutations were introduced at 
residues 123, 124, 314 and 315 as the 
HHd predicts subunit interactions at 
residues 122-130 and the TTd 
predicts involvement of residues 313-
320 (Fig. 4.6). 
 
 
 
Figure 4.6: yeast two-hybrid assay 
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 Table I: Accessible surface areas buried upon formation of elongated dimer.  
HHd TTd 
Elongated Models 
Residue ∆SASA 
(Å2) 
Residue ∆SASA 
(Å2) 
Chain A 
ARG   24 41.4 TRP  211 78.5 
ILE   26 15.4 VAL  212 45.9 
LEU   27 66.5 ARG  213 59.2 
SER   28 32.5 TRP  285 31.7 
TRP   94 14.5 PHE  289 15.3 
LYS   99 28.6 ARG  313 25.9 
ARG  122 40.2 ASP  316 34 
TYR  125 95.5 GLN  318 28.1 
TRP  127 107.5 ARG  320 115 
ASP  128 25.3 ARG  374 58.2 
PRO  129 16.7 ALA  377 16.8 
ASP  130 39.1   
Chain B 
TYR  22 26.2 TRP  211 54.8 
LEU  27 83.7 VAL  212 58.9 
SER  28 40.7 ARG  213 69.8 
ARG  29 40.9 TRP  285 25.5 
ARG  122 28.4 ARG  313 28.2 
TYR  124 23.6 ASP  316 38.4 
TRP  127 54.7 GLN  318 47.3 
TYR  181 30.3 ARG  320 24.9 
  GLU  366 26.5 
  HIS  366 22.5 
  ASP  370 71.5 
  ARG  374 50.1 
         
Subsequently, yeast two-hybrid assays have been performed with these mutants, 
measuring the interaction of a mutant subunit (prey) with wild-type A3G (bait) 
(Huthoff and Malim, unpublished results). In the yeast-two hybrid system, successful 
interaction is indicated by b-galactidase activity in the cell lysate. Indeed, the wild-
type/wild-type (peak 5) control shows a strong signal that is comparable to a positive 
control (peak 2: the TSG101 and VSP28 proteins from the human endosomal sorting 
pathway). Negative controls show low signals (peaks 1, 3 and 4).  A signal 
comparable to the wild-type is observed with mutations at residues 314 and 315 
(peaks 7-9), whereas mutations at 123 and 124 (peaks 10-13) show a signal that 
resembles the negative control. Expression of the wild-type and mutant A3G proteins 
in the yeast cell was confirmed by western blotting (not shown) indicating that loss of 
signal represents a loss of interaction. Thus, this experiment suggests that 
dimerization of A3G is mediated by the N-terminal CDA domain, which corresponds 
to the HHd model. 
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Table II: Accessible surface areas buried upon formation of bent dimer 
HHd TTd 
Bent model 
Residue ∆SASA 
(Å2) 
Residue ∆SASA 
(Å2) 
    
Chain A Chain B Chain A Chain B 
ARG   24 36.9 ARG  14 43.9 PHE  204 24.7 HIS  195 60.9 
ILE   26 47.9 ASP  15 17.7 TRP  211 27.5 SER  196 119.7 
LEU   27 26.4 SER  18 36 VAL  212 70.7 MET  197 50.9 
SER   28 31.6 TYR  19 66.1 ARG  213 84 PRO  199 43.4 
ARG   29 50.8 TYR  22 21 GLY  214 34 PRO  200 19.4 
ARG   30 65.4 ILE  26 32 ARG  215 33.1 THR  203 55.6 
TYR   59 55.6 LEU   27 17.1 HIS  248 26.3 PHE  204 103.1 
LEU   62 43.5 SER   28 33.1 HIS  250 33.9 TRP  211 34.2 
TYR   64 29.9 ARG   29 13.9 GLY  251 30.1 VAL  212 13.4 
THR   98 22.4 ARG   30 26.3 LEU  253 75.5 ARG  213 82.1 
LYS   99 23.2 ASN  31 17 GLU  254 23.3 HIS  216 43.6 
ARG  102 65.7 THR  32 22.1 GLY  255 48.3 GLU  217 25.3 
THR  106 23.6 VAL  58 33.9 PHE  289 40.1 ARG  313 50.5 
ARG  122 40.9 TYR  59 26.3 SER  290 35.7 ASP  317 36.9 
TYR  124 15.5 TRP  94 46.4 GLN  293 26.7 GLN  318 97.9 
TYR  125 57.4 ARG  122 25.5 GLU  294 35.2 ASP  362 41.8 
PHE  126 19.1 PHE  126 37.9 LYS  297 13.6 GLY  363 11.5 
TRP  127 114.9 TRP  127 90.6 TYR  315 22.3 GLU  366 38.9 
PRO  129 65.7 ASN  177 26 ASP  316 17.5 HIS  367 19.7 
GLU  133 66.7 TYR  181 64.5 ASP  317 15.5 ASP  370 67.2 
  LEU  184 74.4 GLN  318 72.2 ARG  374 49.3 
    GLY  319 67.3   
    ARG  320 63.5   
    GLU  323 51.1   
 
To better understand the electrostatic contribution to the dimerization, the potential 
electrostatic surfaces were generated for all systems (Fig.4.7). 
 
  
    
Figure 4.7: Comparison of the electrostatic potential of the predicted modes. In the 
panels A and B the elongated and the bent models of HHd, respectively, are 
displayed. In panels C and D the elongated and the bent models of TTd, 
respectively, are shown. The potential ranges from -10kT (red) to the maximal 
positive value +10kT (blue). 
 
A B
DC
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The electrostatic surface analysis shows that the contacts in the HHd models are 
prevalently formed by positive surfaces (blue coloured surfaces), whereas in the TTd 
models less charged residues are present at the interface. The positive interface in 
the HHd could represent an ideal surface for the interaction of a strong acid molecule 
as ssDNA/RNA. Therefore the absence of such a surface in the TTd and the close 
vicinity of two monomers in the bent model could be used as discrimination criteria 
against it. Lastly, the C-CDA domains would be too hidden in these models to exert 
their activity. 
 
Human APOBEC3F 
 
The models of A3F were constructed with the same procedure adopted for A3G. 
Human APOBEC3F is a protein of 374 amino acids; this provides a shorter protein 
sequence than A3G.  
 
A2   SGGGMIVTGERLPANFFKFQFRNVEYSSGRNKTFLCYVVEAQGKG-GQVQASRGYLED-- 
A3F   MKPHFRNTVERMYRDTFSYNFYNRPILSRRNTVWLCYEVKTKGPSRPRLDAKIFRGQVYS 
 
A2   --EHAAAHAEEAFFNTILPAFDPALR-YNVTWYVSSSPCAACADRIIKTLSKTKNLRLLI 
A3F   QPEH---HAEMCFLSWFCGNQLPAYKCFQITWFVSWTPCPDCVAKLAEFLAEHPNVTLTI 
 
A2   LVGRLFMWEEPEIQAALKKLKEAGCKLRIMKPQDFEYVWQNFVEQEEGESKAFQPWEDIQ 
A3F   SAARLYYYWERDYRRALCRLSQAGARVKIMDDEEFAYCWENFV-YSEGQ--PFMPWYKFD 
 
A2   ENFLYYEEKLADILK*GSGGGMIVTGERLPANFFKFQFRNVEYSSGRNKTFLCYVVEAQGK 
A3F   DNYAFLHRTLKEILR*NP---M----EAMYPHIFYFHFKNLRKAYGRNESWLCFTMEVVKH 
 
A2   GGQVQASRGYLE---DEHAAAHAEEAFFNTIL-PAFDPALRYNVTWYVSSSPCAACADRI 
A3F   HSPVSWKRGVFRNQVDPETHCHAERCFLSWFCDDILSPNTNYEVTWYTSWSPCPECAGEV 
 
A2   IKTLSKTKNLRLLILVGRLFMWEEPEIQAALKKLKEAGCKLRIMKPQDFEYVWQNFVEQE 
A3F   AEFLARHSNVNLTIFTARLYYFWDTDYQEGLRSLSQEGASVEIMGYKDFKYCWENFVYND 
 
A2   EGESKAFQPWEDIQENFLYYEEKLADILK 
A3F   D---EPFKPWKGLKYNFLFLDSKLQEILE  
 
Figure 4.8: Alignment between two monomers of A2 and a whole sequence of A3F.The 
stars indicate the start of monomeric unit of A2. The residue of N-CDA and C-CDA are 
displayed in red and in green, respectively.  
 
The 3D models were generated to predict the dimerization of A3F. MODELLER 
produced only for HHd the two ‘families’ of dimers (Fig. 4.9).  
 
Figure 4.9: The elongate (left )and bent (right) modelobtained from  HHd dimerization 
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As one can see from the analysis of the electrostatic surfaces, the bent TTd would 
lead to a dimer with two negative surfaces in too close contact; may be the repulsion 
of this two surfaces have not allowed the construction of this dimer (Fig.4.10). 
The interface of the dimer HHd appears very similar to that of A3G even though the 
C-CDA domains of A3F show a larger negative surface respect to those of previously 
described. 
 
 
 
 
 
In order to characterize the interaction surface, POPScomp was used [22, 23] to 
detect the residues that were buried upon dimerization (Table III).  
Also in this case a difference of SASA of 15 Å2 was used as cut-off to select the 
residues buried upon formation of the dimer.  
For HHd dimerizations modes the residues correspondent to DPD and YYTW motifs 
are at the interface, in particular the Tyr residue is directly involved in the formation of 
the dimer. In the HHd bent model the residues of monomer A contribute in large part 
to the dimerization surface, whereas only few residues of monomer B are in contact 
with monomer A. 
 Even though there are very few data indicating details on the possible dimeric form 
for A3F, the results obtained from homology modelling and the study of interaction 
surface induce to think that the most plausible dimerization mode is a Head-to-Head 
one, similarly to A3G. 
 
Figure 4.10: Comparison of the electrostatic potential of the predicted modes. (A) 
Elongated HHd, (B) bent HHd and (C) elongated TTd. The potential is ranged from 
-10kT (red) to the maximal positive value +10kT (blue). 
A B
C
 97 
 
Table III: Accessible surface areas buried upon formation of dimer 
HHd TTd HHd 
Elongated Models Bent Model 
Residue ∆SASA 
(Å2) 
Residue ∆SASA 
(Å2) 
Residue ∆SASA 
(Å2) 
Chain A 
TYR   19 18.4 LYS  205 32.2 TYR   22 17 
ARG   24 26.1 LYS  209 51.7 ARG   24 26,6 
LEU   27 59.3 ALA  210 27.3 ILE   26 59,4 
SER   28 43.5 TYR  211 90.8 LEU   27 71,7 
ARG   29 25.8 TRP  277 18.4 SER   28 27,3 
ARG  121 31.8 ARG  305 34.7 ARG   29 185,1 
TYR  123 19.3 TYR  308 92.2 ARG   30 22,5 
TYR  124 39.5 TRP  310 84.2 THR   32 35,7 
TYR  125 12.7 ASP  311 46.5 TYR   59 33 
TRP  126 81.5 ASP  313 16.6 SER   60 21,2 
GLU  127 15.6 PHE  363 15.8 GLN   61 72,8 
LYS  172 35.7   PRO   62 27,1 
PHE  179 42.7   HIS   65 2,1 
Chain B ASP   98 73,9 
ILE  26 21.3 LYS  209 40.3 ARG  121 18,7 
LEU  27 84.4 ALA  210 27.7 TYR  124 37,9 
ARG  29 29.8 TYR  211 94.2 TRP  126 70,3 
TRP  93 30.7 TRP  277 28.1 GLU  127 29,3 
ARG  121 32.5 ARG  305 24.1 ARG  128 99,8 
TYR  124 91 TYR  307 21.3 ASP  129 39 
TYR  125 23.4 PHE  309 22.1 HIS  227 59 
TRP  126 98 TRP  310 82.6 HIS  228 15,8 
GLU  127 47.8 ASP  311 15.1 ASN  266 20 
ARG  128 35.1 ASP  313 35 Chain B 
ASP  129 38.8 PHE  363 29 PHE  5 19,5 
PHE  179 30.5   SER  18 35,8 
    TYR  19 97,7 
    ASN  20 16,5 
    TYR  22 13,4 
    ILE   26 59,8 
    LEU   27 52,3 
    SER   28 68,1 
    ARG   29 126,1 
 
Molecular dynamic simulations 
Molecular Dynamics (MD) simulations  is a useful method to refine the 3D models, 
but also to characterize at the molecular level the effect of specific mutations and 
their perturbation on the overall structure. This technique may be used to investigate 
structural consequences of any given mutation of interest (e.g. Vif-resistant and 
packaging mutants). MD simulations were performed onto the elongated head-to-
head dimerization models of A3F/G as well as onto the crystal structure of 
APOBEC2, used as a reference in our analysis.  
In order to evaluate the stability of the elongated structure of A2 and A3G/F models, 
5 ns and 10 ns of MD simulations were performed on each of these models. As one 
can observe from Fig 4.11, all monomers have reached equilibration within the firsts 
200 ps and show the same average value of RMSD (Root Mean Square Deviation) 
around 2 Å for A2 and 3 Å for A3G/F. The molecules are stable under the simulated 
conditions and converge to similar energy values as shown in Table IV. 
 During the simulations each monomer moves towards each other, getting in closer 
contact and improving this way the interaction. As we can see from Table V, the 
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contacts between the monomers are somewhat 
different, nevertheless in both dimers the residue 
Tyr124 remains in the contact region for all the 
simulated time, in good agreement with the 
experimental data previously described.  
Some interactions are lost during the dynamics, in 
particular for the A3G dimer, where only two (Trp127 
and Tyr 181) of the starting interactions, involving the 
residues of monomer B, remain in contact till the end of 
the simulation. Visual inspection of A3G simulation 
revealed that a new secondary structural segment (helix 
Asn177-Met188) of each monomer causes, after 2 ns, 
the two subunits to move closer to each other. This 
movement influences the position of each monomer and 
causes the loss interactions in another region (Tyr22-
Ser28). A similar situation is observed in A3F, where a 
corresponding helix (Asp174-Leu184) for each 
monomer comes in close contact after few ns. This 
motion observed in both dimers could demonstrate that 
the residues of these helices could play an essential 
role in the dimerization. This observation would suggest 
that these residues could represent good candidates for 
new experiments of site-direct mutagenesis.  
 
Table IV: Energy decomposition analysis of MD simulations 
The first and the last 500 ps of simulations were used for the energy decomposition analysis. 
 
Principal component analysis (PCA) is a powerful tool for finding global, correlated 
motions in atomic simulations of macromolecules [24]. PCA is often used to reduce 
the complexity of the data obtained by MD simulations. The motion is decomposed in 
the principal components, associated to an eigenvector and an eigenvalue. PCA 
analysis performed on the modelled dimmers and on the crystal structure showed 
that in all systems α-carbon fluctuations are almost fully described by the first 10 
eigenvectors. In the A2 simulation the first eigenvector accounts for the 50% of the 
total amount of the motion. In the A3G and A3F the first eigenvector account for the 
56% and 36%respectively. Given that, we decided to analyse the first eigenvector of 
all systems, reducing reasonably the description of the overall motion. In Figure 4.13 
the ‘porcupine’ plots of the first eigenvector of A2, A3G and A3F are shown. This 
analysis revealed that the large part of the observed motion between the two 
monomers of A3G/F is due the residues at the interface 
Energy 
(kJ/mol)  
APOBEC2 
E initial  
APOBEC2 
E final  
      A3G 
E initial  
     A3G 
E final  
      A3F 
E initial  
     A3F 
E final  
Pr-Pr (El)  -21319.8  -21958.3  -20446.5  -21682.9  -20457.2  -21785.4  
Pr-Pr (LJ)  -26493.6  -27202.9  -27570.3  -29014.9  -27679.3  -28945.4  
Pr-Sol (El)  -45859.4  -44159.4  -43159.1  -40086.1  -42958.5  -41345.2  
Pr-Sol (LJ)  -3153.1  -2744.9  -4792.0  -3953.2  -3956.6  -3246.2  
Figure 4.11: RMSD of the Cα 
atoms from their initial 
coordinates as a function of 
time, for the three simulated 
systems; (A) A2, (B) A3G, (C) 
A
B
C
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Table V: Accessible surface areas buried upon formation of dimers.The residues that 
remain in contact during all the simulated time are highlighted in bold.  
 
.  
On the other hand A2 appear more 
rigid and the helices at the interface 
do not interact with each other.  
These very preliminary data could 
lead at the design of new mutants 
and are essential to better clarify at 
molecular level the interactions 
essential for the dimerization. 
 
 
 
 
 
 
 
 
 
3G A3F 
Initial Final Initial Final 
Residue ∆SASA (Å2) Residue 
∆SASA 
(Å2) Residue 
∆SASA 
(Å2) Residue 
∆SASA 
(Å2) 
Monomer A Monomer  A 
ARG   24 41.4 ARG   24 38.7 TYR   19 18.4 TYR   22 26 
ILE   26 15.4 SER   28 15.5 ARG   24 26.1 ARG   24 32.3 
LEU   27 66.5 TRP   94 18.7 LEU   27 59.3 TRP   93 15.2 
SER   28 32.5 ARG  122 17.2 SER   28 43.5 ARG  121 25.1 
TRP   94 14.5 TYR  124 21.4 ARG   29 25.8 TYR  123 17.8 
LYS   99 28.6 PHE  126 81.6 ARG  121 31.8 TYR  124 70.6 
ARG  122 40.2 TRP  127 31.8 TYR  123 19.3 GLU  127 48.5 
TYR  125 95.5 ASN  177 18.2 TYR  124 39.5 ARG  128 15 
TRP  127 107.5 LYS  180 93.2 TYR  125 12.7 ASP  129 25.7 
ASP  128 25.3 TYR  181 31.2 TRP  126 81.5 TYR  171 88.7 
PRO  129 16.7 LEU  184 19.4 GLU  127 15.6 LYS  172 69.4 
ASP  130 39.1   LYS  172 35.7 ASP  174 11.7 
Monomer B PHE  179 42.7 ASP  175 60.6 
TYR  22 26.2 PHE  126 105.8 TYR   19 18.4 PHE  179 50.9 
LEU  27 83.7 TRP  127 92 Monomer  B 
SER  28 40.7 PRO  129 26.1 ILE  26 21.3 LEU  27 148.2 
ARG  29 40.9 ASN  179 21.2 LEU  27 84.4 SER  28 52.7 
ARG  122 28.4 LYS  180 73.2 ARG  29 29.8 TYR  124 48.4 
TYR  124 23.6 TYR  181 48.7 TRP  93 30.7 TYR  125 28.8 
TRP  127 54.7 ILE  183 40.7 ARG  121 32.5 TRP  126 63.5 
TYR  181 30.3 LEU  184 69.3 TYR  124 91 GLU  127 26 
  MET  188 20.8 TYR  125 23.4 ARG  128 126.9 
    TRP  126 98 ASP  129 45.3 
    GLU  127 47.8 ARG  131 71.3 
    ARG  128 35.1 ASN  176 48.8 
    ASP  129 38.8 PHE  179 57.2 
    PHE  179 30.5 THR  183 44.5 
A 
 
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
C 
Figure 4.12: Images of the 
motions corresponding to the 
first eigenvector for 
simulations of A2 (A), A3G 
(B) and A3F (C). Each Cα 
atom has a cone attached 
pointing in the direction of 
motion described in the 
eigenvector for that atom 
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Methods 
Molecular Modelling  
The structures of A3G/F were obtained by homology modelling from the crystal 
structure of human A2 (2NYT pdb entry), with which it shares 30% sequence identity 
with each monomer. 3D dimer models were generated using MODELLER.  
MODELLER is used for homology or comparative modelling of protein three-
dimensional structures [25]. MODELLER implements comparative protein structure 
modelling by satisfaction of spatial restraints [26, 27], and can perform many 
additional tasks, including de novo modelling of loops in protein structures, 
optimization of various models of protein structure with respect to a flexibly defined 
objective function.  
Molecular Dynamics simulations. 
Refinement of the models has been performed by Molecular Dynamics simulations. 
[28, 29]Simulations on the crystal structure of A2 and on the models A3G/F were 
performed with the GROMACS package [30] using the GROMOS96 force field[31]. 
The systems were neutralized and were solvated in a box of  SPC water [32], in a 
solution of 50mM NaCl (20 Na+ and 38 Cl-). All the simulated boxes contained about 
20,000 water molecules. Simulations were carried out at a constant temperature of 
300K. The Berendsen algorithm was applied for the temperature and pressure 
coupling.[33] After a first steepest descent energy minimization with positional 
restraints on the solute, the LINCS algorithm was used to constrain the bonds [34] 
and to carry out an initial 200 ps simulation with the positions of the solute atoms 
restrained by a force constant of 3000 kJ/(mol*nm2) in order to let the water diffuse 
around the molecule and to equilibrate. The particle mesh Ewald method (PME) [35] 
was used for the calculation of electrostatic contribution to non bonded interactions 
(grid spacing of 0.12 nm). The crystal structure of A2 was run for 5 ns whereas the 
models A3G/F for 10 ns each. The Dynamite server (www.biop.ox.ac.uk/) was used 
to produce further PCA analysis of the MD trajectories.  
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